Document:

exv10w1

 

Exhibit 10.1

SEPARATION AGREEMENT AND

WAIVER AND GENERAL RELEASE OF CLAIMS

This SEPARATION AGREEMENT AND WAIVER AND GENERAL RELEASE OF CLAIMS (the “AGREEMENT”) is made
and entered into this 30th day of June 2006 by and between United States Pharmaceutical Group LLC,
d/b/a NationsHealth, Inc. (the “Company”) and Tracy M. Schmidt (“Schmidt”) (collectively the
“Parties”).

WHEREAS, the Parties have mutually agreed that Schmidt will resign from employment with the
Company, effective as of June 2, 2006 (the “Separation Date”), and that the terms of this AGREEMENT
shall supersede the Employment Agreement between Schmidt and the Company, dated April 13, 2005
(“the Employment Agreement”), unless otherwise stated herein;

WHEREAS, the Parties agree that the Company will provide the separation benefits described in
this AGREEMENT in exchange for a waiver and general release of claims against the Company,
including a release of any obligations of the Company under the Employment Agreement;

WHEREAS, Schmidt acknowledges that she would not be entitled to any separation benefits under
the Employment Agreement in the event of her voluntary resignation, and that the separation
benefits provided under this AGREEMENT are considered as future lost wages for the two-year period
commencing June 2, 2006, are in addition to any payments to which she would otherwise be entitled,
and are full and adequate consideration for her waiver and general release of claims under this
AGREEMENT;

NOW, THEREFORE, in consideration of the promises and conditions set forth herein, Schmidt and
the Company agree as follows:

1. Schmidt shall resign from employment with the Company and from all positions that Schmidt
holds at the Company, effective on the Separation Date. Schmidt agrees to cooperate with the
Company in order to ensure an orderly transfer of her duties and responsibilities. Following the
Separation Date, Schmidt shall not represent to anyone that she is an employee of the Company and
shall not say or do anything purporting to represent or to bind the Company.

2. On June 15, 2006, the Company paid to Schmidt all accrued base salary earned but not
previously paid, in the amount of $1,922.88. The Company also paid to Schmidt all unused accrued
paid time off, in keeping with the Company’s policy and practice, in the amount of $6,571.44.
Schmidt acknowledges that these payments represent the full amount of her accrued base salary and
accrued paid time off through the Separation Date, and Schmidt further acknowledges that no further
paid time off time or other benefits will accrue after the Separation Date.

3. Following the Effective Date as set forth in paragraph 13 below, the Company shall provide
Schmidt with the following benefits and payments:

(a) The Company shall pay to Schmidt a separation payment in the amount of five hundred
thousand dollars ($500,000.00). The separation payment shall be paid as follows:

 

 

 

(i) Schmidt shall receive two installments of $10,416.67 (reduced by any applicable
withholding) each month, commencing with the first regular payroll period after the Effective Date
and continuing through December 31, 2006.

(ii) The aggregate installment payments made pursuant to subparagraph (i) (before any
applicable withholding) shall be subtracted from the original $500,000 separation payment, and the
remaining balance (reduced by any applicable withholding) shall be paid 50% in a lump sum on
January 15, 2007, and 50% in a lump sum on July 16, 2007.

(iii) In the event of a change in control of the Company, within the meaning of regulations or
other guidance implementing Internal Revenue Code section 409A(a)(2)(A)(v), any remaining payments
will be accelerated and paid in a lump sum (reduced by any applicable withholding).

(iv) The Parties agree that although Schmidt has had the title of General Counsel and
Executive Vice President Regulatory Operations, Schmidt has not had the duties or authority of a
general counsel or other officer of the Company at any time from January 1, 2005, though her
Separation Date. The facts that form the basis of this conclusion are set forth in Appendix A of
this AGREEMENT. Accordingly, the Parties agree that Schmidt is not subject to the provision in
Internal Revenue Code section 409A(a)(2)(B)(i), which requires that payments to certain officers be
delayed six months following their separation from service. The Company agrees that it will report
any payments made to Schmidt in connection with her separation consistently with this
understanding.

(b) Schmidt’s participation as an active employee in all Company employee benefit plans shall
cease on the Separation Date. The Company shall provide Schmidt with the continuation of medical
coverage in effect on the Separation Date as provided in the Consolidated Omnibus Budget
Reconciliation Act of 1985 (“COBRA”), at the expense of the Company, during the period that Schmidt
or her beneficiaries are eligible to receive coverage under COBRA.

(c) The Company shall fully vest any stock options or restricted stock previously granted to
Schmidt.

(d) The Company agrees to pay Schmidt $100 on the Effective Date as consideration for the
execution of this AGREEMENT.

4. Schmidt acknowledges and agrees that she is resigning voluntarily, that she would not be
entitled to any separation benefits under the Employment Agreement in the event of her voluntary
resignation, and that the payment described in paragraph 3 exceeds any legal payment obligations of
the Company and constitutes full and adequate consideration for her waiver and general release of
claims under this AGREEMENT.

5. In consideration of the payments and mutual promises and covenants set forth in this
AGREEMENT, Schmidt knowingly, freely, and voluntarily enters into this general release and by
signing this general release, Schmidt, on her own behalf and on behalf of her heirs, beneficiaries,
successors, representatives, trustees, administrators, and assigns, hereby waives and releases the
Company, and each of its past, present and future officers, directors, shareholders, employees,
consultants, accountants, attorneys, agents, managers, insurers,

 

- 2 -

 

sureties, parent and sister corporations, divisions, subsidiary corporations and entities,
partners, joint venturers, affiliates, beneficiaries, successors, representatives and assigns (the
“Company Group”) from any and all claims, demands, damages, debts, liabilities, controversies,
obligations, actions or causes of action of any nature whatsoever, whether based on tort, statute,
contract, indemnity, rescission or any other theory or recovery, including but not limited to the
following:

(a) claims arising under the Employment Agreement or arising from Schmidt’s employment, pay,
bonuses, vacation or any other employee benefits, and other terms and conditions of employment or
employment practices of Company Group;

(b) claims relating to the termination of Schmidt’s employment with Company Group or the
circumstances surrounding her termination, or claims growing out of any legal restrictions on the
Company’s right to terminate its employees;

(c) claims arising under federal, state, or local laws prohibiting discrimination in
employment on the basis of race, color, religion, sex, national origin, handicap, disability, age
or any other category protected by law under Title VII of Civil Rights Act of 1964, the Civil
Rights Act of 1991, Executive Order 11246, the Equal Pay Act, the Americans With Disabilities Act,
the Rehabilitation Act of 1973, the Age Discrimination in Employment Act of 1967, the Employee
Retirement Income Security Act, the Older Workers Benefits Protection Act, the Consolidated Omnibus
Budget Reconciliation Act of 1985, the Worker Adjustment and Retraining Notification Act (“WARN”),
the Occupational Safety and Health Act, the Family and Medical Leave Act (“FMLA”), the Florida
Civil Rights Act (as any of these laws may have been amended) or any other similar labor,
employment, or anti-discrimination laws;

(d) claims for compensatory, punitive, equitable or other relief, whether known or unknown,
suspected or unsuspected, against the Company Group, including without limitation claims that might
have arisen or might in the future arise in connection with any event that occurred on or before
the date of Schmidt’s execution of this release; or

(e) claims based on any contract, tort, whistleblower, personal injury, or wrongful discharge
theory.

The Parties further agree that, in consideration of the promises, agreements, and covenants
set forth herein, the Company knowingly, freely, and voluntarily releases Schmidt from any and all
claims, demands, damages, debts, liabilities, controversies, obligations, actions, or causes of
action of any nature whatsoever, whether based on tort, statute, contract, indemnity, rescission,
or any other theory of recovery, including but not limited to claims arising under federal, state,
or local laws. Moreover, the Company agrees that should legal proceedings, other than those that
she has agreed to waive and release, arise that involve the performance of her assigned duties with
the Company, the Company will indemnify Schmidt for any and all reasonable expenses and costs
associated with representation in such proceedings, including attorneys’ fees, expert fees, and
related costs and expenses, and Schmidt agrees that retention of counsel for the Company and
Schmidt for any such matter(s) shall be the sole responsibility of the Company.

6. Schmidt expressly waives any right or claim of right to assert hereafter that any claim,
demand, obligation and/or cause of action has, through ignorance, oversight or error, been omitted
from the terms of the general release contained in paragraph 5. Schmidt makes this waiver with
full knowledge of her rights and with specific intent to release both her known and

 

- 3 -

 

unknown claims, and therefore specifically waives provisions of applicable law, which reads as
follows:

“A general release does not extend to claims which the creditor does not know or suspect to
exist in his favor at the time of executing the release, which if known by him must have materially
affected his settlement with the debtor.”

Schmidt understands and acknowledges the significance and consequence of the general release
and of such waiver and expressly agrees that this AGREEMENT shall be given full force and effect
according to each and all of its express terms and provisions, including those relating to unknown
and unsuspected claims, demands, obligations, and causes of action herein above specified.

7. To the extent permitted by law, Schmidt agrees that Schmidt shall not initiate or cause to
be initiated against the Company Group any compliance review, suit, action, investigation or
proceeding of any kind, or voluntarily participate in same, unless required to by law through
subpoena, court order, or other similar directive, individually or as a representative, witness, or
member of a class, under contract, law, or regulation, whether federal, state, or local, pertaining
to any matter related to her employment with the Company, and Schmidt represents that she has not,
to date, initiated (or caused to be initiated) any such review, suit, action, investigation, or
proceeding.

8. Schmidt agrees she shall return to the Company on or before the Separation Date any
building key(s), security pass or other access or identification cards and any and all Company
property in her possession, including but not limited to any books, documents, credit cards,
computer equipment, software, mobile phones, data files, notes, and written information (and all
copies thereof) furnished by the Company and its subsidiaries or affiliates or prepared by Schmidt
in the course of Schmidt’s employment by the Company and its subsidiaries or affiliates. Schmidt
agrees to submit all expense accounts and to pay promptly the outstanding balance on each corporate
credit card that the Company previously issued to Schmidt.

9. Schmidt agrees that she and her agents will not publicize or disclose, directly or
indirectly, the existence of this AGREEMENT, the terms thereof, or the circumstances giving rise to
the AGREEMENT, to anyone other than Schmidt’s attorney, accountant, financial advisor and members
of her immediate family or as required by law. Schmidt further agrees that she will advise any
individual to whom the terms, conditions, or existence of this AGREEMENT have been disclosed of the
confidentiality requirements of this paragraph and that she will use her best efforts to ensure
that the confidentiality requirements of this paragraph are complied with in all respects.

10. Schmidt understands and agrees that her covenant to comply with the following
non-competition, non-solicitation, and non-disparagement obligations serves as material inducement
for the Company to enter into this AGREEMENT and that her obligations under this paragraph 10
survive the termination of this AGREEMENT. Further, Schmidt understands and agrees that her breach
of the obligations set forth in this paragraph 10 would be a material breach of this AGREEMENT,
entitling the Company to all available remedies at law and equity, including, but not limited to,
recoupment of the payments made to Schmidt under paragraph 3 of this AGREEMENT.

 

- 4 -

 

(a) Non-Competition. Schmidt acknowledges and recognizes her possession of
Confidential Information (as defined in her Employment Agreement with the Company) and acknowledges
the highly competitive nature of the business of the Company and its affiliates and subsidiaries
and accordingly agrees that, in consideration of the promises contained herein, she will not, from
the Separation Date and for a period of one (1) year following the Separation Date (the
“Post-Employment Restricted Period”), engage or invest in, own, manage, operate, finance, control,
or participate in the ownership, management, operation, financing, or control of, be employed by,
lend her name to, lend her credit to, or render services or advice to any business that competes
with the business then being conducted by the Company or any of its affiliates or subsidiaries (or
that had been conducted by the Company or any of its affiliates or subsidiaries during the prior 12
months), provided, however, that Schmidt may purchase or otherwise acquire up to three percent of
any class of securities of any enterprise if such securities are listed on any national or regional
securities exchange or have been registered under Section 12(g) of the Securities Exchange Act of
1934, as amended. Schmidt agrees that, in consideration of the promises contained herein, she will
not, either individually or as an officer, director, stockholder, member, partner, agent,
consultant or principal of any other business firm, directly or indirectly, solicit any business of
the type being carried on by the Company or any of its affiliates or subsidiaries during the
Post-Employment Restricted Period (or any business of a similar type) from any person or entity
that was a customer of the Company or its affiliates or subsidiaries during the term of her
employment with the Company. This paragraph shall not restrict Schmidt’s right to practice law to
the extent (but only to the extent) that such a restriction would violate Florida professional
conduct rule 4-5.6.

(b) Non-Solicitation. Schmidt recognizes that she does possess confidential
information about employees of the Company and its subsidiaries or affiliates relating to their
education, experience, skills, abilities, compensation, and benefits, and inter-personal
relationships with suppliers to and customers of the Company and its subsidiaries and affiliates.
Schmidt recognizes that the information she possesses about these other employees is not generally
known, is of substantial value to the Company and its subsidiaries or affiliates in developing
their respective businesses and in securing and retaining customers, and has been acquired by
Schmidt because of her engagement with the Company. Schmidt agrees that, for one year after the
Separation Date, Schmidt will not, directly or indirectly, solicit or recruit any employee of the
Company or any of its subsidiaries or affiliates of the purpose of becoming employed by Schmidt or
by any business, individual, partnership, firm, corporation or other entity on whose behalf Schmidt
is acting as an agent, representative or employee and that Schmidt will not convey any such
confidential information or trade secrets about employees of the Company or any of its subsidiaries
or affiliates to any person.

(c) Non-Disparagement. Except as required by subpoena or court order, Schmidt further
agrees, in exchange for the consideration identified in paragraph 3 above, that in any and all
conversations, writings, or communications by herself regarding Company or any of its employees,
she shall make no negative, derogatory, or defamatory statements concerning the Company Group.
Schmidt further agrees that she will not directly or indirectly contact members of the press or
media; any federal, state, or local governmental agency; any past, present, or future employees of
the Company; or any past, present or future customers or contracting parties of the Company, in
order to disparage the reputation or business practices of Company. Schmidt agrees that any
disparaging or negative statement about Company by Schmidt shall be a material breach of this
AGREEMENT.

 

- 5 -

 

11. This AGREEMENT constitutes a compromise settlement of disputed and contested matters
between the Parties and is the product of arms-length negotiations. It shall not be construed as
an admission of any sort by either of the Parties, nor shall it be used as evidence in a proceeding
of any kind, except one in which one of the Parties alleges breach of the terms of this AGREEMENT
or one in which one of the Parties elects to use this AGREEMENT as a defense to any claim.

12. By signing this AGREEMENT, Schmidt acknowledges and agrees that:

(a) she has been afforded a reasonable and sufficient period of time for deliberation thereon
and for negotiation of the terms thereof;

(b) she has carefully read and understands the terms of this AGREEMENT;

(c) she has signed this AGREEMENT freely and voluntarily and without duress or coercion and
with full knowledge of its significance and consequences and of the rights relinquished,
surrendered, released, and discharged hereunder;

(d) the only consideration for signing this AGREEMENT are the terms stated herein and no other
promise, agreement, or representation of any kind has been made to her by any person or entity
whatsoever to cause her to sign this AGREEMENT;

(e) that the Company did offer her a minimum period of at least twenty-one (21) days after her
receipt of this AGREEMENT to review it; and

(f) that the Company advised her that she had the opportunity to consult an attorney before
signing this AGREEMENT.

13. This AGREEMENT may be revoked, in a writing sent to the Chairman of the Company, by
Schmidt at any time during the period of seven (7) calendar days following the date of execution by
Schmidt. If such seven (7) day revocation period expires without Schmidt’s exercising her
revocation right, the obligations of this AGREEMENT will become fully effective on the eighth day
after Schmidt’s execution of the AGREEMENT (the “Effective Date”).

14. This AGREEMENT constitutes an integrated agreement, containing the entire understanding of
the Parties with respect to the matters addressed herein except for the HIPAA Confidentiality and
Need to Know Agreement and the Employee Confidentiality Agreement between the Company and Schmidt
(the “Confidentiality Agreements”), which Confidentiality Agreements remain in full force and
effect. Except as set forth in this AGREEMENT, no representations, warranties or promises have
been made or relied on by the Parties. This AGREEMENT shall prevail over any prior communications
between the Parties or their representations relative to matters addressed herein.

15. It is the desire and intent of the parties hereto that the provisions of this AGREEMENT
shall be enforced to the fullest extent permissible under the law and public policies applied in
each jurisdiction in which enforcement is sought. Accordingly, although Schmidt and the Company
consider the restrictions contained in this AGREEMENT to be reasonable for the purpose of
preserving the Company’s goodwill and proprietary rights, if any particular provision of this
AGREEMENT shall be adjudicated to be invalid or unenforceable, such provision shall be deemed
amended to delete the portion adjudicated to be invalid or unenforceable, such deletion to apply
only with respect to the operation of such business in the

 

- 6 -

 

particular jurisdiction in which such adjudication is made. It is expressly understood and
agreed that although the Company and Schmidt consider the restrictions contained in paragraph 10 to
be reasonable, if a final determination is made by a court of competent jurisdiction that the time
or territory or other restriction contained in this AGREEMENT is unenforceable against Schmidt, the
provisions of this AGREEMENT shall be deemed amended to apply as to such maximum time and territory
and to such maximum extent as such court may judicially determine or indicate to be enforceable.

The Parties acknowledge that the Company’s damages at law would be an inadequate remedy for
the breach by Schmidt of any of the provisions of paragraph 10, and agree that in the event of such
breach the Company may obtain temporary and permanent injunctive relief restraining the Schmidt
from such breach, and, to the extent permissible under the applicable statutes and rules of
procedure, a temporary injunction may be granted immediately upon the commencement of any such
suit. Nothing contained herein shall be construed as prohibiting the Company from pursuing any
other remedies available at law or equity for such breach or threatened breach of paragraph 10, or
for any breach or threatened breach of any other provision of this AGREEMENT.

Further, the Parties agree that any claim, controversy, or dispute between Schmidt and the
Company (including without limitation Company’s affiliates, subsidiaries, officers, employees,
representatives or agents) arising out of or related to this AGREEMENT, other than a dispute
concerning a breach or a threatened breach of paragraph 10 of this AGREEMENT, shall be submitted to
and settled by arbitration before a single arbitrator in a forum of the American Arbitration
Association (“AAA”) located in Broward County in the State of Florida and conducted in accordance
with the National Rules for the Resolution of Employment Disputes. In such arbitration: (a) the
arbitrator shall agree to treat as confidential evidence and other information presented by the
parties to the same extent as Confidential Information must be held confidential by Schmidt under
the terms of her prior employment and under the terms of this AGREEMENT, (b) the arbitrator shall
have no authority to amend or modify any of the Company’s policies, and (c) the arbitrator shall
have ten business days from the closing statements or submission of post-hearing briefs by the
parties to render a decision. All AAA-imposed costs of said arbitration, including the
arbitrator’s fees, if any, shall be borne by the Company. All legal fees incurred by each party in
connection with said arbitration shall be borne by the party who incurs them, unless applicable
statutory authority exist providing for the award of attorneys’ fees to a prevailing party and the
arbitration decision and award provides for the award of such fees. Any arbitration award shall be
final and binding upon the Parties, and any court having jurisdiction may enter a judgment on the
award.

16. The Company may withhold from any compensation or other benefits payable to Schmidt under
this AGREEMENT any federal, state, or local income or employment tax that the Company reasonably
determines to be due with respect to the distribution. Schmidt shall remain responsible at all
times for paying all taxes due with respect to any payment under this AGREEMENT, and the Company
shall not be liable for any interest or penalty that Schmidt incurs by failing to make timely
payments of tax.

17. The Parties agree that a failure by any party at any time to require performance of any
provision of this AGREEMENT shall not waive, affect, diminish, obviate or void in any way

 

- 7 -

 

that party’s full right or ability to require performance of the same, or any other provisions
of this AGREEMENT, at any time thereafter.

18. This AGREEMENT shall be binding upon, and shall inure to the benefit of, the parties
hereto and their heirs, successors, assigns, and personal representatives. As used herein, the
successors of the Company shall include, but shall not be limited to, any successor by way of
merger, consolidation, sale of all or substantially all of its assets, or similar reorganization.
The Company shall require any successor (whether direct or indirect, by purchase, merger,
consolidation, liquidation, or otherwise) to all or substantially all of the business and/or assets
of the Company to assume all outstanding obligations of the Company under this AGREEMENT.

19. This AGREEMENT shall be interpreted, enforced and governed under the laws of the State of
Florida, without regard to conflict of laws principles.

20. The Parties warrant and represent that they have read and understand the foregoing
provisions of this AGREEMENT and that they and their respective signatories are fully authorized
and competent to execute this AGREEMENT on behalf of each of them. Schmidt further warrants and
represents that she has not previously assigned or transferred any of claims that are the subject
of the release contained herein.

Executed as an agreement under seal effective as of eight (8) days after Schmidt’s execution
of this AGREEMENT.

	 	 	 	 	 	 	 	 	 
	NATIONSHEALTH, INC.	 	 	 	TRACY M. SCHMIDT
	 
	 	 	 	 	 	 	 	 
	By:

	 	/s/ Robert Tremain
	 	 	 	By:
	 	/s/ Tracy M. Schmidt
	 

	 	 
	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	Title:

	 	Chief Operating Officer
	 	 	 	Date:
	 	06/30/06
	 

	 	 
	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	Date:

	 	06/30/06	 	 	 	 	 	 
	 

	 	 	 	 	 	 	 	 

 

- 8 -

 

Exhibit 10.1

APPENDIX A

It is agreed by the Parties that although Schmidt had the title “General Counsel and Executive
Vice President Regulatory Operations,” she did not have the duties or authority of a general
counsel or other officer of the Company. Specifically, Schmidt was never elected as an officer by
the Company’s board of directors; she never had the authority to negotiate or enter into binding
agreements on behalf of the Company; she never had responsibility for establishing or overseeing
the Company’s relationship with its outside counsel; she was listed as a “key employee” rather than
as an officer in the Company’s 2005 proxy statement; she was not identified as an officer in any
securities law filing of the Company; and she exercised only the authority associated with the job
duties listed below.

Job duties from January 1, 2005 — April 2006

Supervised functions related to the Company’s diabetic mail order
division, including sales, reorder, customer service, pharmacy, and
distribution. Daily job duties included:

	 	(i)	 	reviewing operational reports
prepared by the finance department to evaluate the
performance of the operations, e.g. sales numbers,
reorder calls, cancellation rates, etc.

	 
	 	(ii)	 	meeting with members of the
management team including the VP of Regulatory Affairs,
VP Pharmacy Services, VP Marketing, and VP
Distribution.

	 
	 	(iii)	 	coordinating operations
meetings among members of operations management.

	 
	 	(iv)	 	identifying opportunities for
system improvements in the operations.

	 
	 	(v)	 	discussing operating results
with the COO, CFO, and/or CEO.

 

A - 1exv10w2

 

Exhibit 10.2

 

 

AMENDED AND RESTATED

PREFERRED VENDOR AGREEMENT

BY AND AMONG

CONNECTICUT GENERAL LIFE INSURANCE COMPANY

and

UNITED STATES PHARMACEUTICAL GROUP, LLC and

NATIONSHEALTH, INC.

as of

 

 

May 26, 2006

 

 

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

 

 

This AMENDED AND RESTATED PREFERRED VENDOR AGREEMENT (this “Agreement”), dated as of May 26,
2006 (the “Effective Date”), is made and entered into by and between Connecticut General Life
Insurance Company, a Connecticut corporation, (“CIGNA”), and UNITED STATES PHARMACEUTICAL GROUP,
LLC, a Delaware limited liability company, (“USPG”) and NATIONSHEALTH, INC., a Delaware corporation
and the indirect owner of all of the membership interest of USPG (“NationsHealth”).

WHEREAS, the Medicare Prescription Drug Benefit program was established by Section 101 of the
Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (the “MMA”) and is codified
in Sections 1860D-1 through 1860D-41 of the Social Security Act (the “Act”) and created a new Part
D, known as the Voluntary Prescription Drug Benefit Program (hereinafter referred to as “Part D”);

WHEREAS, CIGNA submitted an application to the Centers for Medicare and Medicaid Services
(“CMS”) under Part D to become a Prescription Drug Plan (“PDP”) sponsor in each of the thirty-four
Part D regions designated by CMS;

WHEREAS, CIGNA, USPG and NationsHealth entered into this Agreement (then known as a Strategic
Agreement) on May 4, 2005, as amended by the parties on October 4, 2005, and February 20, 2006;

WHEREAS the parties now desire to amend and restate this Agreement in its entirety as
described herein;

NOW, THEREFORE, in consideration of the covenants set forth in this Agreement, and for other
good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the
Parties agree as follows:

ARTICLE I

SERVICES AND OBLIGATIONS OF USPG

SECTION 1.01 General Responsibilities. USPG shall provide to CIGNA the services
(collectively, the “Services”) set forth in this Article I. The Services shall consist of the
activities enumerated in Section 1.02 for all CMS contract years, the activities enumerated in
Sections 1.03 through 1.06 for the 2006 CMS contract year, and those enumerated in Section 1.07 for
subsequent CMS contract years. The Parties agree that the Services as described in Exhibits
1.03, 1.04, 1.05 and 1.06 were agreed to at the beginning of Part D. From that time through
the Effective Date, the Parties’ actual experience with Part D has added clarity regarding the
requirements for the performance of the Services, or which Party should take responsibility for the
performance of specific Services. As a result, from time to time the Parties have mutually agreed
to adopt certain adjustments to the Services and the standards pertaining thereto that may differ
from those described in Exhibits 1.03, 1.04, 1.05 and 1.06. The Parties hereby agree that
these mutually agreed upon adjustments will continue in effect for the remainder of the 2006 CMS
contract year. Thereafter, the Services, and the standards pertaining thereto, will be governed by
Exhibits 1.07 and 5.04. The Services shall be performed, at a minimum, consistent with the
timeliness, accuracy and quality standards set forth in CMS instructions and guidelines,
provided, however, that the Parties may agree to standards in addition, or in excess
of, those established by CMS.

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

2

 

SECTION 1.02 Part D Capabilities. USPG will develop the systems and infrastructure
required to perform the Services in conformance with CMS regulations and guidance, as described in
Exhibit 1.02.

SECTION 1.03 Marketing and Beneficiary Communication. USPG will provide marketing and
beneficiary communication services in conformance with CMS regulations and guidance, as described
in Exhibit 1.03 and consistent with the standards of performance described therein.

SECTION 1.04 Enrollment Billing and Premium Collection. USPG will provide Enrollee
billing and collection services, including, but not limited to, Enrollee-specific premium billing,
and collection information in support of financial reporting and reconciliation processes, all in
conformance with CMS regulations and guidance, as described in Exhibit 1.04 and consistent
with the standards of performance described therein.

SECTION 1.05 Enrollment and Eligibility. USPG will provide Enrollee management entry
point and servicing in conformance with CMS regulations and guidance, as described in Exhibit
1.05 and consistent with the standards of performance described therein. USPG will also
provide disenrollment management in conformance with CMS regulations and guidance, as described in
Exhibit 1.05 and consistent with the standards of performance described therein.

SECTION 1.06 Enrollee Inquiries and Grievance Processing. USPG will be responsible
for Enrollee inquiries and grievance processing in conformance with CMS regulations and guidance,
as described in Exhibit 1.06 and consistent with the standards of performance described
therein.

SECTION 1.07 Services Related to the 2007 and Subsequent CMS Contract Years. USPG
will make available the services as described in Exhibit 1.07 and consistent with the
standards of performance described therein and in conformance with CMS regulations and guidance as
described in Exhibit 1.07.

SECTION 1.08 Services Expense Authorization. In connection with any expenditure for
the NationsHealth CIGNA-Funded Interim Service Expenses as defined in Exhibit 3.01 the
Parties shall issue a joint Purchase Order in the form attached Exhibit 1.08. Any payment
obligations incurred by a Party pursuant to the issuance of a Joint Purchase Order shall survive
the termination of this Agreement for any reason and shall remain an obligation of such Party to be
allocated between the Parties in accordance with the terms of Exhibit 3.01, Interim
Compensation.

SECTION 1.09 NationsHealth Develpomental Costs. NationsHealth and/or USPG will fund
the NationsHealth Developmental Costs described in Exhibit 1.09.

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

3

 

ARTICLE II

REPRESENTATIONS AND WARRANTIES OF CIGNA

     SECTION 2.01 CIGNA hereby represents and warrants to USPG and NationsHealth as follows:

(a) Corporate Status; Authorizations. CIGNA is a corporation duly incorporated,
validly existing and in good standing under the Laws of the State of Connecticut. CIGNA has the
corporate power and authority, and all licenses, permits or other authorizations required for CIGNA
to carry on its business as now conducted and as contemplated by this Agreement, except where the
failure to possess any such authority, authorization, licenses, permits or other authorizations
would not have a Material Adverse Effect. The execution, delivery and performance of this
Agreement by CIGNA have been duly authorized by all necessary corporate action of CIGNA and this
Agreement constitutes the valid and binding obligations of CIGNA enforceable against it in
accordance with their terms, except as may be limited by bankruptcy, insolvency, moratorium or
other similar Laws affecting creditors’ rights generally, and subject to general principles of
equity (regardless of whether enforcement is considered in a proceeding in equity or at law).

(b) Part D Qualification. CIGNA is a risk bearing entity licensed to provide health
insurance benefits in each of the fifty states and the District of Columbia; has, or will develop,
a pharmacy network that meets, or will meet, CMS access standards for a PDP sponsor; and otherwise
qualifies for one or more Part D contracts.

(c) Part D Contract Requirements. CIGNA will comply with all of the requirements
imposed by any Part D Contract it executes with CMS, provided, however, that CIGNA’s
failure to comply with any Part D Contract requirements will not be grounds for termination of this
Agreement unless CMS terminates the Part D Contract based on CIGNA’s failure to comply.

(d) State Licensure. CIGNA will continuously maintain all appropriate state insurance
licenses, permits, or qualifications for the provision of its services to Enrollees under the PDP.

SECTION 2.02 Developmental Costs. CIGNA will develop the systems and infrastructure
described in Exhibit 2.02.

ARTICLE III

COMPENSATION

SECTION 3.01 Determination of Compensation Through December 31, 2006. The
compensation to USPG for its Services as described in this Agreement shall be determined as
described in Exhibit 3.01, Interim Compensation, for the period through December 31, 2006.

SECTION 3.02 Determination of Compensation for Services Related to the 2007 and Subsequent
Plan Years. The compensation to USPG for its Services as described in this

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

4

 

Agreement shall be determined as described in Exhibit 1.07 for the CMS contract years
beginning January 1, 2007, January 1, 2008, and January 1, 2009.

SECTION 3.03 Acceptance of Preferred Vendor Status. CIGNA has designated USPG as a
Preferred Vendor in connection with the provision of the Services.

SECTION 3.04 Triggers for, Payment of, and Computation of Preferred Vendor Fee.

(a) Triggers for Preferred Vendor Fee. USPG shall be entitled to a Preferred Vendor
Fee with respect to the applicable CMS contract years in the event of the following conditions:

	 	(i)	 	in the 2007 CMS contract year, if CIGNA directs
that USPG provide the Services to less than ***;

	 	(ii)	 	in the 2008 CMS contract year, if CIGNA directs
that USPG provide the Services to less than *** and the *** to is less
than ***; and,

	 	(iii)	 	in the 2009 CMS contract year, if CIGNA
directs that USPG provide the Services to less than *** and the *** of
*** to is less than ***.

(b) Payment of Preferred Vendor Fee. Within forty-five (45) days of the end of each
calendar quarter, CIGNA will calculate whether USPG has earned an interim Preferred Vendor Fee for
that quarter based on (A) the existence of conditions (i) or (ii) or (iii), above, and (B) the
excess, if any, of the year-to-date *** of *** for the applicable contract year over the ***
actually ***. If earned by USPG, CIGNA shall pay the interim Preferred Vendor Fee to USPG before
the last day of such forty-five (45) day period. Within forty-five (45) days of the end of each
CMS contract year, CIGNA shall reconcile all interim Preferred Vendor Fees paid during the year
against the total Preferred Vendor Fee actually due and owing, if any, for such year based on the
formula set forth in this Section 3.04. USPG or CIGNA, as the case may be, shall pay to the other
any amount owing to the other as determined by such reconciliation within ten (10) days of the last
day of such forty-five (45) day period.

(c) Computation of Preferred Vendor Fee. The Preferred Vendor Fee shall be equal to
*** multiplied by the excess, if any, of the following respective *** over the *** of *** actually
*** in accordance with this Agreement during the applicable CMS contract year:

	 	(i)	 	for the 2007 CMS contract year, ***;

	 
	 	(ii)	 	for the 2008 CMS contract year *** or all of
the ***;

	 	(iii)	 	for the 2009 CMS contract year, *** or all of
the ***.

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

5

 

ARTICLE IV

ADDITIONAL AGREEMENTS

     SECTION 4.01 Legal and Regulatory Compliance.

(a) Each Party shall carry out its duties and obligations under this Agreement in material
compliance with all applicable Laws. USPG shall provide Services under this Agreement to Enrollees
in accordance with the terms and conditions of this Agreement and in a manner consistent with the
requirements of the Medicare statutes, regulations, CMS guidance and CIGNA policies, including but
not limited to CIGNA’s CMS-required compliance programs with respect to Medicare Part D, as amended
from time to time, and training thereon, provided, however, that such policies and
compliance programs, as amended, shall have been furnished in writing to USPG which shall have a
reasonable period of time for their implementation. With respect to CIGNA policies other than
CIGNA’s CMS-required compliance program, CIGNA shall not require compliance by NationsHealth in
excess of that required from CIGNA’s other Part D subcontractors. USPG shall maintain all
applicable licenses required to carry out its business activities and shall further comply with
CIGNA policies and procedures and all applicable laws and regulations to ensure that its Services
are provided in a culturally competent manner to Enrollees, including those with limited English
proficiency or reading skills, diverse cultural and ethnic backgrounds, and physical or mental
disabilities.

(b) USPG, in its status as a first tier Part D contracting entity, shall cooperate in CIGNA’s
implementation of CMS’ Prescription Drug Benefit Manual Chapter 9—Part D Program to Control Fraud,
Waste and Abuse (“Chapter 9”). USPG shall promptly investigate any suspected incidents of fraud,
waste and abuse and cooperate fully with any CMS, Medicare Integrity Contractor, or law enforcement
investigations thereof to the extent applicable to USPG’s responsibilities under this Agreement.
USPG shall further cause any Part D downstream entities or related entities, as such entities are
defined in Chapter 9, to cooperate in CIGNA’s implementation of Chapter 9. The Parties agree to
work together to determine Chapter 9’s applicability to USPG.

(c) In the event that USPG is required by regulatory authorities to obtain additional licenses
necessary to permit it to perform the Services, or USPG determines that it is required to obtain
such licenses, or in the event that CIGNA concludes in good faith after reasonable investigation
that USPG is required to obtain such licenses, and USPG does not possess such licenses, then USPG
shall have a period of ninety (90) days within which to file applications for such licenses. If,
after one hundred twenty (120) days from the last day of such ninety (90) day period USPG does not
possess at least *** of such licenses, then CIGNA shall be entitled to terminate this Agreement For
Cause pursuant to Section 5.04(a), ***, that in such instance the notice requirement and cure
period contained in Section 5.04(a) shall not apply.

(d) In the event that USPG is ordered or otherwise formally requested by regulatory
authorities to cease performing any of the Services, then USPG shall cease performing such Services
in accordance with such order or formal request.

(e) If either of the events described in subsections (c) or (d), above, occurs, CIGNA may
directly or through a third party, solicit and/or service Part D Enrollees in the

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

6

 

state(s) or jurisdictions(s) with respect to which USPG is unable to so solicit and/or service
because of its lack of licensure or the application of a governmental order or formal request that
it cease such activities in such state(s) or jurisdiction(s).

     SECTION 4.02 Inspection, Audit and Acceptance.

(a) CIGNA, its Affiliates, and CMS shall have the right, directly or through their designated
auditors, at all reasonable times to inspect, audit, or otherwise evaluate the work performed or
being performed by USPG, its supporting policies and procedures, including those related to data
security, disaster recovery and back-up, as well as all data supplied, in the performance of this
Agreement. If any inspection or evaluation is made by CIGNA or CMS on the premises of USPG or any
of USPG’s suppliers, USPG or its suppliers shall provide at no additional charge all reasonable
facilities and assistance for the safety and convenience of the personnel conducting the inspection
or evaluation. The Secretary of Health and Human Services, the Comptroller General of the U.S.
Government Accountability Office, or their designees shall have the right during the term of this
Agreement and for a period of ten (10) years after termination of this Agreement or the date of the
audit completion, whichever is later, to audit, evaluate, or inspect any books, contracts, medical
records, documents, papers, enrollee documentation, and other records of USPG, related entity,
subcontractor, or transferee that pertain to any aspect of the Services provided under this
Agreement, or as the Secretary may deem necessary to enforce the applicable Medicare Contract
between CMS and CIGNA. Any audit, evaluation, or inspection covered by this Section 4.02(a) shall
be at no additional charge to CIGNA, but each Party will be responsible for its own labor and out
of pocket expenses. USPG and NationsHealth further represent, warrant, and covenant to CIGNA that,
in connection with the performance of the Services hereunder, USPG and/or NationsHealth will not
hold Enrollees liable for fees that are the responsibility of CIGNA.

(b) All Services provided by USPG for CIGNA, its Affiliates, and the Enrollees shall be in
accordance with the requirements of this Agreement, including all schedules, annexes, exhibits and
attachments, and shall be subject to rejection if such Services are nonconforming. No inspection
or evaluation performed by CIGNA, its Affiliates, or CMS shall in any way relieve USPG of its
obligation to furnish all required Services in strict accordance with the requirements of this
Agreement. If any of the Services do not conform to the requirements of this Agreement, CIGNA
shall have the right to require USPG to take such steps as are reasonably necessary to bring its
performance into compliance including, but not limited to, requiring USPG to perform the work or
services again in conformity with the applicable requirements at no cost to CIGNA or CMS.

     SECTION 4.03 Representations and Covenants of USPG and NationsHealth.

(a) Contracting Capacity. USPG and NationsHealth represent, warrant and covenant
that (1) as to themselves and their principals within the last five years, and (2) their employees
and subcontractors that will be assigned to perform Services hereunder within the five-year period
preceding their initial performance hereunder, to USPG and NationsHealth’s Knowledge: (i) are not
debarred, suspended, proposed for debarment or suspension, or otherwise excluded or declared
ineligible for the award of contracts by or participation in any Federal program, department or
agency; (ii) have not been charged with, convicted of or had a civil

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

7

 

judgment rendered against them for: commission of a fraud or a criminal offense in connection with
obtaining, attempting to obtain, or performing a public (Federal, state, or local) contract or
subcontract; dishonesty or breach of trust including but not limited to violation of Federal or
state antitrust statutes, commission of a fraud including but not limited to mail fraud or false
representations, violation of fiduciary relationship, securities offenses, embezzlement, theft,
forgery, bribery, falsification or destruction of records, making false statements, tax evasion, or
receiving stolen property; (iii) have not been indicted for, or otherwise criminally or civilly
charged by a government entity (Federal, state, or local) with, commission of any of the offenses
enumerated in this Section; (iv) have not had one or more public agreements or transactions
(Federal, state, or local) terminated for cause or default; and (v) have not been excluded from
participation for a federal program, including but not limited to, Medicare, Medicaid, federal
health care programs or federal behavioral health care programs pursuant to Title XI of the Social
Security Act, 42 U.S.C. § 1320a-7 and other applicable federal statutes. USPG and NationsHealth
also represent, warrant, and covenant to CIGNA that USPG and/or NationsHealth have or will duly
obtain all intellectual property rights necessary to perform its obligations under this Agreement.
USPG and NationsHealth’s certification in this Section is a material representation of fact upon
which CIGNA relied when this Agreement was entered into by the Parties. USPG and/or NationsHealth
shall provide immediate written notice to CIGNA if, at any time during the term of this Agreement,
USPG and/or NationsHealth learns that its certification in this Section was erroneous on the
Effective Date of this Agreement or has become erroneous by reason of new or changed circumstances.
If the circumstances causing such certification to be erroneous are curable, then USPG and
NationsHealth shall have forty-five (45) days to cure such circumstances. Furthermore, if the
circumstances causing such certification to be erroneous relate to a non-compliant employee or
subcontractor in connection with Section 4.03(a)(2), above, then USPG and NationsHealth shall be
deemed to have timely cured such circumstances, so long as USPG and/or NationsHealth completely
removes such employee or subcontractor from performing any Services hereunder immediately upon
learning that such employee or subcontractor is non-compliant with this Section. Subject to the
foregoing cure provisions, if it is later determined that USPG’s and/or NationsHealth’s
certification in this Section was erroneous on the original Effective Date (May 4, 2005) of this
Agreement or has become erroneous by reason of new or changed circumstances, in addition to other
remedies available to CIGNA, CIGNA may terminate this Agreement for convenience, at its sole
discretion.

(b) Exclusions and Debarment Certifications. NationsHealth and USPG shall
certify that (i) they have reviewed the HHS OIG exclusions and GSA debarment lists prior to hiring
an employee or manager performing or responsible for any duties under this Agreement and (ii) any
employee, downstream entity, or related entity who performs or is responsible for Part D duties
under this Agreement who appears on such lists has been removed from any work directly or
indirectly related to a federal health care program. The certifications shall be executed annually
and delivered to CIGNA not later than thirty (30) days following the end of each calendar year for
which this Agreement is effective.

(c) Conflict of Interest Certifications. NationsHealth and USPG shall execute a
conflict of interest statement, attestation, or certification that they are free of any conflict of
interest in administering Part D benefits. The statement, attestation, or certification by
NationsHealth and USPG shall be executed annually and delivered to CIGNA not later than

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

8

 

thirty (30) days following the end of each calendar year for which this Agreement is effective.
NationsHealth and USPG shall further cause any related or downstream entities with Part D
responsibilities under this Agreement to execute and deliver annual conflict of interest
statements, attestations, or certifications to NationsHealth and USPG. This subsection (c) is not
intended to preclude NationsHealth or USPG from contracting with other Part D plan sponsors or CMS.

(d) Corporate Status; Authorizations. NationsHealth and USPG, respectively, are a
corporation and a limited liability company duly incorporated or organized, validly existing and in
good standing under the Laws of the state of Delaware. NationsHealth and USPG have the corporate
power and authority, and all licenses, permits or other authorizations required to carry on their
businesses as now conducted and as contemplated by this Agreement, except where the failure to
possess any such authority, authorization, licenses, permits or other authorizations would not have
a Material Adverse Effect and except as set forth on Exhibit 4.03(d). The execution,
delivery and performance of this Agreement by NationsHealth and USPG have been duly authorized by
all necessary corporate action and this Agreement constitutes the valid and binding obligations of
NationsHealth and USPG enforceable against them in accordance with their terms, except as may be
limited by bankruptcy, insolvency, moratorium or other similar Laws affecting creditors’ rights
generally, and subject to general principles of equity (regardless of whether enforcement is
considered in a proceeding in equity or at law).

SECTION 4.04 Warranting and Certification of Data. Certain of the data (the “CMS
data”) furnished by USPG or NationsHealth in connection with its performance of its obligations
under this Agreement will be used by CIGNA to obtain payments from CMS, to support CIGNA’s bids for
Medicare Program renewals and contracts with CMS in future years, or both. CIGNA and CMS will be
acting in reliance on the accuracy, completeness, and truthfulness of any CMS data USPG or
NationsHealth provides. USPG and NationsHealth agree to warrant the accuracy, completeness, and
truthfulness of the CMS data it furnishes pursuant to this Agreement to CMS and to indemnify and
hold CIGNA harmless for any payments made by CIGNA and any damages or liabilities caused by the
negligence or willful misconduct of USPG or NationsHealth or that of their employees or agents in
connection with providing inaccurate, incomplete, or untruthful CMS data. Any CMS data that are
provided pursuant to this Agreement on a monthly, quarterly, or annual basis shall be certified by
the duly authorized Chief Executive Officer, the Chief Financial Officer or other officer of USPG
who reports directly to NationsHealth’s Chief Executive Officer or Chief Financial Officer. With
respect to any data furnished by USPG and/or NationsHealth that CIGNA or its Affiliates will
incorporate into data certified to CMS such certification shall state:

“I hereby certify that the data, information and statements set forth herein are
accurate, complete, truthful and current to the best of my knowledge, information, and
belief after reasonable investigation with respect thereto, and are made in good faith.

Signed:

     Certifying Officer”

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

9

 

SECTION 4.05 Compliance with Grievance Requirements. If and to the extent that USPG
processes Enrollee grievances, then USPG shall cooperate and comply with all requirements of
Medicare and CIGNA regarding the processing of Enrollee grievances as defined under Part D and
accompanying CMS regulations, including the obligation to provide information (including medical
records and other pertinent information) to CIGNA within the time frame reasonably requested for
such purpose, and shall process such grievances in accordance with Exhibits 1.05 and
1.07.

SECTION 4.06 Privacy and Security of Certain Data. The Parties expect to be
responsible for obtaining, analyzing, storing, transmitting, and reporting Protected Health
Information, as defined in regulations, 45 CFR Parts 160 and 164, implementing the Health Insurance
Portability and Accountability Act of 1996, Pub. L. 104-191 (“HIPAA”). The Parties agree to comply
with all applicable Federal and State privacy and security laws including but not limited to the
requirements of HIPAA and its implementing regulations and 42 CFR § 423.136 as more fully described
in the Business Associate Agreement in the form attached as Exhibit 4.06.

SECTION 4.07 Assignment and Subcontracting. Except as described on Exhibit
4.07, USPG and NationsHealth are solely responsible for the provision of the Services and their
other obligations under this Agreement. Neither USPG nor NationsHealth may assign or transfer, in
whole or in part, these obligations, any interest in this Agreement or any claim under this
Agreement. Neither the entirety nor any part of this Agreement or any task order may be further
subcontracted by USPG or NationsHealth without the prior written consent of CIGNA. CIGNA’s
consent to the proposed replacement of USPG or NationsHealth’s contractors shown on Exhibit
4.07 shall not be unreasonably withheld.

SECTION 4.08 Advance Consent to Assignment Among Affiliates of CIGNA. USPG and
NationsHealth consent in advance to CIGNA’s assignment or transfer of all or part of its rights and
obligations of under this Agreement to any CIGNA subsidiary or Affiliate (including any successor
company of CIGNA pursuant to a reorganization by CIGNA and one or more of its Affiliates). Any
such assignment and transfer shall be effective upon delivery of a written notice of assignment by
CIGNA to USPG or NationsHealth and shall be subject to Section 10.05 of this Agreement.

SECTION 4.09 Delegation of Duties. The parties acknowledge that CIGNA oversees and is
accountable to CMS for any functions or responsibilities described in CMS’ Medicare Program
regulations and, upon becoming a sponsor of the PDP, will monitor the performance of USPG on an
ongoing basis. USPG and NationsHealth shall perform their obligations under this Agreement in a
manner consistent with and in compliance with CIGNA’s contractual obligations under CIGNA’s
Medicare contract with CMS. In the event that CIGNA delegates to USPG or NationsHealth any function
or responsibility imposed pursuant to CIGNA’s contract with CMS, such delegation shall be subject
to the requirements set forth in 42 C.F.R.§ 423.505(i)(4), as they may be amended over time. In
addition, any delegation by USPG or NationsHealth of functions or responsibilities imposed pursuant
to this Agreement shall be subject to the prior written approval of CIGNA and shall also be subject
to the requirements set forth in 42 C.F.R. § 423.505(i)(4), as they may be amended over time. USPG
and NationsHealth shall promptly supplement and amend their permitted subcontracts to include CMS’
requirements applicable to subcontractors. USPG and
NationsHealth agree that CIGNA or its Affiliates may, at their option, outsource various functions
of its Medicare contract with CMS.

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

10

 

SECTION 4.10 Document Retention, Audit Rights. Each Party shall retain, in accordance
with standard and accepted practices, such financial, accounting, and administrative records
related to the services it is obligated to provide under this Agreement for such period as is
necessary to comply with applicable Law, but in no event less than ten (10) years after the date
such documents and information are created or obtained, or longer under the conditions enumerated
in 42 CFR§ 423.505(e)(4). Subject to applicable Law, during the term of this Agreement CIGNA, on
one hand, and USPG and NationsHealth, on the other hand, may reasonably conduct (or have conducted
on its behalf), at its own expense, one audit each year of the other Party with respect to relevant
documents and data in the possession of such other Party and with reasonable access to relevant
personnel of such other Party upon reasonable notice solely for the purposes of confirming
compliance with obligations undertaken pursuant to this Agreement including those that are required
to be reported to an applicable government agency; provided, however, that such
audits may be performed more frequently to the extent necessary to respond to a request by CMS or
another government agency. The terms of the confidentiality provisions set forth in Article VII
hereof shall apply to any such audits. Such audit rights will be available following termination of
this Agreement to the extent necessary to respond to a request by a customer, Governmental
Authority, provider or other relevant party and for a Party’s need to manage litigation and to
determine compliance with this Agreement or applicable Laws.

SECTION 4.11 Cash Balance Information Access. NationsHealth shall provide CIGNA with
daily password protected, read-only access to its aggregate cash balances, as well as weekly
electronic reports with respect to its weekly cash balances. The foregoing daily access and weekly
reporting requirements shall be suspended as of the date on which NationsHealth has had at least
$10 million in aggregate cash balances for a period of 180 consecutive days, and shall be replaced
by NationsHealth’s provision of a monthly statement to CIGNA of its aggregate cash balances until
such time as NationsHealth’s monthly cash balance falls below $5 million. Thereafter,
NationsHealth’s obligation to provide daily password protected, read-only access to its aggregate
cash balances and weekly electronic reports to CIGNA with respect to its weekly cash balances shall
resume.

SECTION 4.12 Notice of Material Changes in Enrollment Levels. CIGNA shall use its
best efforts to provide NationsHealth with reasonable advance notice of anticipated material
changes in enrollment levels in the PDP to permit NationsHealth to facilitate its capacity planning
activities.

ARTICLE V

AGREEMENT CONTINGENT;

TERM AND TERMINATION

SECTION 5.01 Agreement Contingent on CMS Acceptance of CIGNA Applications. This
Agreement is expressly contingent upon CMS’ acceptance of the applications submitted by CIGNA and
the award of Part D contracts to CIGNA.

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

11

 

SECTION 5.02 Term of this Agreement. The initial term of this Agreement shall be
from the Effective Date until December 31, 2009. This Agreement shall renew for successive one (1)
year renewal terms thereafter unless either Party provides written notice of nonrenewal to the
other not later than July 1 of any one-year renewal term or the final year of the initial term.

SECTION 5.03 Termination. Each Party may terminate this Agreement For Cause by
providing written notice to the other Party, provided, however, that neither of USPG or
NationsHealth may cause a termination of this Agreement by providing a notice of termination to the
other. If For Cause notice is given regarding any of the events set forth in Section 5.04 (a), (b),
(c), and (f) the effective date of termination shall be either (i) the expiration of the applicable
cure period, or (ii) if there is no applicable cure period, forty-five (45) days after the date
written notice of termination is received by the other Party. In the event a For Cause notice is
given regarding any of the events set forth in Section 5.04(d) or (e) the effective date of
termination will be the date that such notice is received by the other Party.

SECTION 5.04 For Cause. “For Cause” termination shall mean the following:

(a) As to a nonbreaching Party, the other Party’s breach of any of
the terms
and conditions of this Agreement that causes a Material Adverse Effect on the non-breaching Party,
and remains uncured following written notice and a reasonable opportunity to cure, which shall not
be less than ninety (90) days from the date of written notice of such breach.

(b) As to a nonbreaching Party, if a default occurs on a payment required to
be made by the breaching Party relating to the PDP.

(c) As to a nonbreaching Party, if a Party is adjudicated to have committed
fraud in a civil proceeding or otherwise settles a civil fraud action involving the United States
for a material amount, or a criminal action is filed by a governmental agency against a Party
arising out of, or relating to, the PDP, or a Party is excluded or debarred from participation in
any federal or state health care program pursuant to 42 U.S.C. § 1320a-7.

(d) As to a nonbreaching Party, if a Party: (i) is unable to pay its debts generally as they
become due; (ii) makes a voluntary assignment for the benefit of creditors; (iii) is declared
insolvent in any proceeding; (iv) commences a voluntary case or other proceeding seeking
liquidation, reorganization or other relief with respect to itself, any of its property, assets or
debts under any bankruptcy, insolvency or other similar laws now or hereafter in effect or
petitions or applies to any tribunal for the appointment of a receiver, liquidator, custodian or
trustee for such Party under any bankruptcy, reorganization, arrangement, insolvency, readjustment
of debt, liquidation, or dissolution law of any jurisdiction now or hereafter in effect; or (v) is
named as a debtor party in such petition, application, case or proceeding and it indicates its
approval thereof, consents thereto, acquiesces therein or acts in furtherance thereof, or if such
petition, application, case or proceeding is not dismissed or stayed for a period of sixty (60)
days after it is commenced, or is the subject of any order appointing any such receiver,
liquidator, custodian or trustee or approving the petition in any such case or proceeding.

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

12

 

(e) If NationsHealth’s aggregate cash balances are below *** at the end of any week (a “Cash
Balance Deficiency”), provided, however, that CIGNA has not withheld or delayed payments to
NationsHealth to cause a Cash Balance Deficiency.

(f) As to CIGNA, a failure by NationsHealth and/or USPG to comply with one or more of the
Service Levels contained in Exhibit 5.04 that causes CIGNA to incur a Material Adverse
Effect and which remains uncured following written notice and a reasonable opportunity to cure,
which shall not be less than thirty (30) days from the date of written notice of such failure.

SECTION 5.05 Optional Extension of Counter-Party Performance in Connection With Early
Termination. Following the termination of this Agreement prior to the initial term described
in Section 5.02 pursuant to Section 5.04 (a), (b) or (c), above, the party subject to a termination
For Cause shall, at the election of the other party, agree to honor the terms and conditions of
this Agreement through December 31 of the year following the year in which the termination is
effective, or such shorter time as the party requesting performance may specify, provided
however, that if such a continuation of performance creates a substantial financial hardship to
USPG, then the parties shall meet and confer in good faith concerning potential compensation to
USPG based on a fee-for-service or “cost plus” basis for the duration of USPG’s continued
performance.

SECTION 5.06 Right of First Refusal of Offer to Accept Assignment of CIGNA’s Contract
with CMS; Right of First Refusal of Offer to Receive the Transfer of Enrollees as of Next Open
Enrollment Period; Option to Acquire Servicing Assets; Rights in Cardholder Data; No Preclusion on
Marketing by USPG and NationsHealth.

(a) Right of First Refusal of Offer to Accept Assignment of CIGNA’s Contract with
CMS. If NationsHealth or USPG (or NationsHealth or USPG and a third party or parties) is the
sponsor or contractor, in a material capacity, for a CMS-approved PDP (the “NationsHealth PDP”),
then NationsHealth shall have the right to match the terms and conditions of an offer acceptable to
CIGNA from a third-party PDP sponsor for the assignment to such third party of CIGNA’s contract
with CMS regarding the CIGNA PDP that CIGNA receives prior to CIGNA’s acceptance of such offer.
CIGNA shall inform NationsHealth of any such offer within ten (10) days of CIGNA’s receipt of the
offer and NationsHealth shall have a period of ten (10) days thereafter to notify CIGNA in writing
that it matches or does not match the terms and conditions of the offer. If NationsHealth matches
the offer, CIGNA shall accept NationsHealth’s offer subject to any CMS or other requirements under
law relating to the novation of CIGNA’s contract with CMS.

(b) Right of First Refusal of Offer to Receive the Transfer of Enrollees as of Next Open
Enrollment. If CIGNA decides to cease offering any PDP and receives an offer from a
third-party PDP sponsor under which such third-party PDP sponsor would compensate CIGNA for its
efforts to facilitate the transfer of the Enrollees into such third-party PDP sponsor’s PDP as of
the then-next open enrollment cycle, which offer is acceptable to CIGNA, then NationsHealth shall
have the right to match the terms and conditions of such offer prior to CIGNA’s acceptance of the
offer, provided that NationsHealth or USPG (or NationsHealth or USPG and a third party or parties)
is the sponsor or contractor, in a material capacity, for a CMS-

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

13

 

approved PDP (the “NationsHealth PDP”). CIGNA shall inform NationsHealth of such offer within
ten (10) days of the CIGNA’s receipt of the offer, and NationsHealth shall a have a period of ten
(10) days thereafter to notify CIGNA in writing that it matches or does not match the terms and
conditions of the offer. If NationsHealth does not notify CIGNA in writing within such period,
NationsHealth’s right to match the offer shall expire as of the last day of such period. If
NationsHealth matches the offer, CIGNA shall accept NationsHealth’s offer subject to any CMS or
other requirements under law relating to the facilitation of the transfer of enrollees. If legally
permissible, the Parties will effect such transfer of enrollment through Enrollee communications
and any other activities necessary to support such transfer in accordance with the terms of any
required CMS approval and applicable Law, including, without limitation, HIPAA, pursuant to which
CIGNA shall provide NationsHealth and/or USPG with information on such Enrollees to the extent
necessary to enable NationsHealth and/or USPG to market the NationsHealth PDP to such Enrollees.

(c) Option to Acquire Servicing Assets. In the event of a termination of this
Agreement by CIGNA For Cause pursuant to subsections (a), (d), (e), or (f) of Section 5.04, above,
or in the event that USPG and NationsHealth change their business operations such that they no
longer offer the Services, then CIGNA shall have the option to acquire, which option must be
exercised within thirty (30) days of the final date on which USPG renders Services pursuant to this
Agreement, the assets required to deliver all or part of the Services described in Exhibits
1.02, 1.03, 1.04, 1.05, 1.06 and 1.07. CIGNA shall
have the option to acquire such physical assets from USPG and/or NationsHealth at their fair market
value. NationsHealth may decline to sell such physical assets to CIGNA, in which instance CIGNA
may acquire similar assets from third party vendors. NationsHealth and/or USPG will provide know
how, expertise, and personnel resources to assist CIGNA, without cost to CIGNA, in replicating the
functionality of such assets. Prior to the effective date of such termination, CIGNA may notify
USPG or NationsHealth of CIGNA’s intent to exercise such option so that the transfer of such assets
will occur simultaneously with the termination. Further, in the event of such termination, CIGNA
shall have the option to acquire from USPG and/or NationsHealth, without cost to CIGNA, the
intangible assets required to deliver all or part of the Services, including system specifications
and configurations, software code, training and policy manuals, marketing plans and other
information used by USPG or NationsHealth in the performance of the Services described in the
foregoing exhibits through a grant by USPG and/or NationsHealth to CIGNA of a royalty-free
perpetual license for such intangible assets to the extent of the authority of USPG and/or
NationsHealth to grant such a license.

(d) No Loss of Rights in Cardholder Data; No Preclusion on Marketing by USPG and
NationsHealth. No termination of this Agreement shall be deemed by CIGNA to constitute a
transfer or assignment by USPG or NationsHealth to CIGNA of data developed by USPG or NationsHealth
concerning participants in NationsHealth’s prescription card program or to constitute a prohibition
on marketing activities by NationsHealth or USPG with respect to such participants.

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

14

 

ARTICLE VI

CONFIDENTIALITY; USE OF INTELLECTUAL PROPERTY;

ENROLLEE DATA; EXCLUSIVITY

SECTION 6.01 Confidentiality. Prior to entering into this Agreement the Parties have
each committed substantial resources to developing the arrangements described in this Agreement.
The Parties specifically acknowledge that to induce each other to enter into this Agreement each
Party specifically confirms that all Confidential Information received from the other party at any
time shall remain confidential during the term of this Agreement and shall be used only in
furtherance of the business relationships contemplated by the provisions of this Agreement. In
this regard, each Party agrees that any Confidential Information provided to it will only be
provided to its employees on a “need to know” basis, and will be treated with at least as much care
as the receiving party provides for its own Confidential Information (and in no event treated with
any less than a high degree of confidentiality.)

SECTION 6.02 Use of Proprietary Information.

(a) Notwithstanding anything to the contrary in this Agreement, NationsHealth and USPG
reserves all right, title and interest in and to, and all control of the use of NationsHealth or
USPG’s copyrights, patents, service marks, trademarks, designs, logos, brand names, Internet “URL”
addresses, World Wide Web sites and all right, title and interest in and to any trade names,
fictitious business names, and all other intellectual property rights (collectively,
“NationsHealth/USPG Intellectual Property”), including all right, title and interest, including any
license rights it has, in and to the name of NationsHealth or USPG, and any derivation thereof and
including NationsHealth/USPG New Intellectual Property (as defined below). CIGNA shall not, and
shall ensure that CIGNA’s Affiliates do not, use any of NationsHealth/USPG Intellectual Property in
materials supplied to Employer Groups, prospective Employer Groups, Enrollees or otherwise without
NationsHealth’s and USPG’s express and specific prior written consent. To the extent applicable,
CIGNA hereby assigns, transfers and conveys irrevocably and perpetually to NationsHealth or USPG
all of its worldwide right, title and interest in and to any and all NationsHealth/USPG
Intellectual Property. “NationsHealth/USPG New Intellectual Property” means all developed
materials and other intellectual property that (a) are conceived, created or developed in
connection with or in the course of providing the Services and are modifications, enhancements,
adaptations or derivative works of or derived from or based on the NationsHealth Data or any
NationsHealth/USPG Intellectual Property in all cases, regardless of who makes such modifications,
enhancements, adaptations and derivative works but specifically excluding modifications,
enhancements, adaptations or derivative works of or derived from or based on the CIGNA Data or any
CIGNA Intellectual Property, or (b) are conceived, created or developed to address, execute or
embody a NationsHealth/USPG-specific product, service, business process, including any
modifications, enhancements, adaptations and/or derivative works of or based on any of the
foregoing, in all cases, regardless of who conceives, creates, develops or makes any of the
foregoing. For the avoidance of doubt, “NationsHealth/USPG New Intellectual Property” does not
include CIGNA Intellectual Property generally applicable to CIGNA’s business.

(b) Notwithstanding anything to the contrary in this Agreement, CIGNA and its Affiliates
reserve all right, title and interest in and to, and all control of the use of, CIGNA’s copyrights,
patents, service marks, trademarks, designs, logos, brand names, Internet “URL” addresses, World
Wide Web sites and all right, title and interest in and to any trade names, fictious business names
and all other intellectual property rights (collectively “CIGNA Intellectual Property”) including
all right, title and interest, including any license rights it has, in

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

15

 

and to the names “CIGNA,” “CIGNA HealthCare,” “CIGNA Companies,” “Connecticut General Life
Insurance Company,” and any derivation thereof and including CIGNA New Intellectual Property. USPG
and NationsHealth shall not, and shall ensure that USPG’s and NationsHealth’s Affiliates do not,
use any CIGNA Proprietary Information in materials supplied to Employer Groups, prospective
Employer Groups, Enrollees or otherwise without CIGNA’s prior express and specific prior written
consent. To the extent applicable, USPG and NationsHealth hereby assign, transfer and convey
irrevocably and perpetually to CIGNA all of their worldwide right, title and interest in and to any
and all CIGNA Intellectual Property. “CIGNA New Intellectual Property” means all developed
materials and other intellectual property that (a) are conceived, created or developed in
connection with or in the course of providing the Services and are modifications, enhancements,
adaptations or derivative works or derived from or based on the CIGNA Data or CIGNA Confidential
Information or any CIGNA Intellectual Property in all cases, regardless of who makes such
modifications, enhancements, adaptations and derivative works of or derived from or based on the
CIGNA Data or any CIGNA Intellectual Property but specifically excluding modifications,
enhancements, adaptations and derivative works derived from or based on the NationsHealth Data or
any NationsHealth /USPG Intellectual Property, or (b) are conceived, created or developed to
address, execute or embody a CIGNA-specific product, service, business process, including any
modifications, enhancements, adaptations and/or derivative works of or based on any of the
foregoing, in all cases, regardless of who conceives, creates, develops or makes any of the
foregoing. For the avoidance of doubt, “CIGNA New Intellectual Property” does not include
NationsHealth/USPG Intellectual Property generally applicable to USPG’s or NationsHealth’s
business.

SECTION 6.03 Data. The use and management of CIGNA Data by USPG and/or NationsHealth
shall be as described in Exhibit 6.03. The use and management of NationsHealth Data by
CIGNA shall be as described in Exhibit 6.03.

ARTICLE VII

SURVIVAL; INDEMNIFICATION

SECTION 7.01 Survival of Representations and Warranties. Notwithstanding any
investigation made by or on behalf of the Parties hereto, the results of any such investigation, or
the knowledge of USPG or NationsHealth or knowledge of CIGNA (regardless of how obtained), the
representations and warranties contained in Articles II and IV hereof and the indemnification
obligations of the Parties with respect thereto, and the provisions of Article VIII, shall survive
the expiration or termination of this Agreement for a period of one (1) year following such
expiration or termination, subject to the terms and conditions of this Article VII.

SECTION 7.02 Mutual Indemnification.

(a) Subject to the terms and conditions of this Article VII, USPG and NationsHealth shall hold
harmless and indemnify CIGNA and its Affiliates from any claims, losses, damages, liabilities,
costs, expenses or obligations, including reasonable attorney’s fees and expenses related to the
performance of this Agreement (collectively, “Losses”) that arise out of or result from (i) the
breach of any representation or warranty of USPG under this Agreement, or (ii) the negligence or
willful misconduct of USPG, its officers, employees and agents in the performance of USPG’s
obligations under this Agreement.

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

16

 

(b) Subject to the terms and conditions of this Article VII, CIGNA shall hold harmless and
indemnify USPG and NationsHealth from any Losses that arise out of or result from (i) the breach of
any representation or warranty of CIGNA under this Agreement, or (ii) the negligence or willful
misconduct of CIGNA, its officers, employees and agents in the performance of CIGNA’s obligations
under this Agreement.

SECTION 7.03 Method of Asserting Third-Party Claims.

(a) As used in this Agreement, “Notifying Party” refers to any Party who claims entitlement to
indemnification under Section 7.02 for losses resulting from a third-party claim. The
“Indemnifying Party” refers to the Party obligated to indemnify the Notifying Party under Section
7.02.

(b) In the event any Notifying Party is made a defendant in or party to any claim instituted
by any third party for which the Notifying Party may be entitled to indemnification under Section
7.02, the Notifying Party shall give the Indemnifying Party prompt notice thereof. The failure to
give such notice shall not affect any Notifying Party’s ability to seek reimbursement unless, and
only to the extent that, such failure has a detrimental effect on the Indemnifying Party’s ability
to defend successfully the claim. The Indemnifying Party shall be entitled to contest and defend
such claim, provided that the Indemnifying Party: (i) has a reasonable basis for concluding that
such defense may be successful; and (ii) diligently contests and defends such claim.

(c) Notice of the intention so to contest and defend shall be given by the Indemnifying Party
to the Notifying Party within fifteen (15) business days after the Notifying Party’s notice of such
claim. The Indemnifying Party shall use reputable attorneys of its choosing to conduct such
contest and defense. The Notifying Party shall be entitled at any time, at its own cost and
expense (which expense shall not constitute a Loss for which the Notifying Party can be indemnified
under Section 7.02), to participate in such contest and defense and to be represented by attorneys
of its own choosing. The Notifying Party shall give the Indemnifying Party notice that it intends
to participate in such contest and defense.

(d) If the Notifying Party elects to participate in such defense, the Notifying Party shall
cooperate with the Indemnifying Party in the conduct of the defense. Whether or not the Notifying
Party elects to participate in such defense, neither the Notifying Party nor the Indemnifying Party
may concede, settle or compromise any claim without notifying the other Party and without the
Indemnifying Party’s consent if the settling party is the Notifying Party, which consent shall not
be unreasonably withheld.

(e) Notwithstanding any provision in this Agreement to the contrary, if: (i) a claim from a
third party seeks relief in the form of a material obligation of the Notifying Party other than an
obligation to pay monetary damages; (ii) the subject matter of a claim relates to the ongoing
business of the Notifying Party, which claim, if decided against the Notifying Party, would
adversely effect the ongoing business (including, without limitation, requiring any material change
in the business practices of the Notifying Party) of the Notifying Party; or (iii) the Notifying
Party would not be fully indemnified under Section 7.02 or released with respect to such claim,
then, in each such case, the Notifying Party shall be entitled to contest and defend

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

17

 

such claim, the expense of which shall constitute a Loss for which the Notifying Party can be
indemnified under Section 7.02 (and the Indemnifying Party may participate); provided,
however, that any settlement or compromise shall require the consent of the Indemnifying
Party, which consent shall not be unreasonably withheld, and, if the Notifying Party does not
contest and defend such claim, the Indemnifying Party shall then have the right to contest and
defend (but not settle) such third party claim.

(f) Any dispute between the Parties about the applicability of any Party’s indemnification
rights or obligations under Section 7.02 or the method of asserting claims under this Section 7.03
shall be resolved in accordance with the dispute resolution provisions set forth in Article VIII.

SECTION 7.04 Limitations on Indemnification. Except as set forth in Article VIII, the
rights set forth in Section 7.02 shall be each Party’s sole and exclusive remedies against the
other Party hereto for any Losses. No Party shall be entitled to any recovery under this Agreement
for its own special, consequential, incidental or punitive damages. The limitations set forth in
this Section 7.04 shall not apply to any Losses that have resulted proximately from any fraudulent
act of the Indemnifying Party or its directors, officers, employees, agents or representatives.

SECTION 7.05 Insurance. During the term of this Agreement, the Parties shall each
maintain adequate insurance related to the operation of their respective businesses and their
respective obligations under this Agreement.

ARTICLE VIII

DISPUTE RESOLUTION

SECTION 8.01 Disputes. This Article VIII sets forth the sole source of remedies
available to the Parties with regard to any and all disputes between them arising in connection
with this Agreement (hereinafter referred to as “Disputes”) including all questions of
arbitrability, the existence, validity, scope or termination of this Agreement or any term thereof;
provided, however, that the Parties agree that money damages may not be an adequate
remedy for any breach of the provisions of this Agreement and that a Party may, in its discretion,
apply to a court of law or equity of competent jurisdiction located in a venue set forth in Section
10.09 for specific performance and injunctive relief in order to enforce or prevent any violations
of this Agreement and any Party against whom such proceeding is brought hereby waives the claim or
defense that such Party has an adequate remedy at law and agrees not to raise the defense that the
other Party has an adequate remedy at law. The Parties shall work together in good faith to resolve
any and all Disputes.

SECTION 8.02 Commencing Arbitration. If the parties are unable to resolve any such
Dispute or agree upon appropriate action within thirty (30) days following the date one Party sent
written notice of the Dispute, or such other period of time as mutually agreed between the Parties,
and if a Party wishes to pursue the Dispute, such Party may thereafter submit the Dispute to
binding arbitration in accordance with the American Arbitration Association’s Procedures for Large,
Complex Commercial Disputes, as they may be amended from time to time (see http://www.adr.org).
Any arbitration proceeding under this Agreement shall be conducted in Hartford, Connecticut. The
arbitrator(s) may construe or interpret but shall not vary or ignore the

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

18

 

terms of this Agreement and shall be bound by controlling Law. The arbitrator(s) shall have
no authority to award special, consequential, incidental or punitive damages.

SECTION 8.03 Decision Binding; Federal Arbitration Act. The decision of the
arbitrator(s) regarding the Dispute will be binding, and judgment on the award may be entered in
any court having jurisdiction thereof. The Parties acknowledge that because this Agreement affects
interstate commerce, the Federal Arbitration Act applies.

SECTION 8.04 Waiver; Survival. In the event any court determines that this
arbitration procedure is not binding or otherwise allows litigation involving a Dispute to proceed,
the Parties hereby waive any and all right to trial by jury in, or with respect to, such
litigation. This Article VIII shall survive any termination of this Agreement.

ARTICLE IX

DEFINITIONS

SECTION 9.01 Defined Terms.

When each of the following terms is used in this Agreement it shall have the meaning stated
below:

“Affiliate” with respect to any Person means a Person that directly or indirectly, through one
or more intermediaries, Controls, is controlled by, or is under common control with, the first
mentioned Person.

“CIGNA Data” means, collectively, all data and information (a) relating to providers,
enrollees, and customers of CIGNA, or (b) CIGNA’s Confidential Information, or (c) CIGNA’s
Intellectual Property, or (d) to which USPG or NationsHealth have access by or through CIGNA in
connection with the provision of the Services, or (e) any and all knowledge, experience or know-how
gained by CIGNA during the course of this Agreement.

“Confidential Information” means information about a Party’s customers, business practices and
procedures, and the proprietary business information of a Party.

“Contract” means any written or oral contract, agreement, commitment, insurance policy,
arrangement or understanding.

“Control” (including the terms “controlled by” and “under common control with”) means the
possession, directly or indirectly or as member or trustee, of the power to direct or cause the
direction of the management or policies of a Person, whether through the ownership of stock or as
member or trustee, by Contract or credit arrangement or otherwise.

“Domiciled” means the locality in which an Employer Group’s principal executive offices are
located.

“Dual Eligibles” means persons who are eligible for both Medicare and Medicaid.

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

19

 

“Employer Group” means any employer, labor union, Governmental Authority or other legally
organized group of individuals, and the covered dependents of the persons associated therewith, or
an entity which directly or indirectly contracts to provide a prescription drug benefit, including
an employer-sponsored nonstatutory customized Medicare “wrap” or PDP program.

“Enrollee” or “Part D Enrollee” means each eligible persons enrolled directly, or indirectly,
in a CIGNA-sponsored PDP.

“Governmental Authority” means any government or political subdivision thereof, whether
federal, state or local (including counties and cities), or any court, agency, commission,
department, district, or other instrumentality of any such government or political subdivision.

“Law” means the common law and any statute, ordinance, code or other law, rule, regulation,
order, standard, requirement or procedure enacted, adopted, promulgated, applied or followed by any
Governmental Authority with proper jurisdiction over the Parties, or the activities of the Parties.

“Material Adverse Effect” means any change, effect, fact, event or circumstance that,
individually or when taken together with all such other changes, effects, facts, events or
circumstances is or may reasonably be expected to be materially adverse to the condition (financial
or otherwise), results of operations, business, properties, prospects, assets, liabilities, or
operations of a Party’s business, as the case may be, or to the ability of a Party to consummate
the transactions contemplated by this Agreement.

“Medicare Program” means, collectively, the programs created by Congress in the Act, including
without limitation, the implementation of the Medicare Part D Prescription Drug Benefit Program,
including any regulations or CMS pronouncements and any future amendments.

“NationsHealth Data” means, collectively, (a) all data and information concerning customers,
participants, and prospects of USPG or NationsHealth, excluding Part D-specific Data developed in
connection with this Agreement, or (b) NationsHealth’s or USPG’s Confidential Information, or (c)
NationsHealth/USPG Intellectual Property, or (d) any and all knowledge, experience or know-how
gained by NationsHealth or USPG during the course of this Agreement.

“Part B Supplies” means medical supplies consisting of, but not limited to, prescription
drugs, durable medical equipment, diabetes supplies, oxygen or other respiratory supplies, and
ostomy supplies and any related services that are furnished by the supplier to Medicare
beneficiaries on an outpatient basis and that are reimbursed under Part B of the Medicare program.

“Parties” means USPG, NationsHealth, and CIGNA and its Affiliates.

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

20

 

“Person” means an individual, corporation, partnership, association, limited liability
company, trust, unincorporated organization, Governmental Authority or other entity or group (as
defined in Section 13(d) of the Securities Exchange Act of 1934, as amended).

“Preferred Vendor” means a vendor with which CIGNA has contracted, or to which CIGNA has
assigned responsibility, for the provision of Services or similar services in consideration for,
among other things, a Preferred Vendor Fee.

“Preferred Vendor Fee” means the fee described in Section 3.04 of this Agreement.

“Tax” means any federal, state, county, local, foreign or other tax (including, without
limitation, income taxes, premium taxes, excise taxes, sales taxes, use taxes, gross receipts
taxes, franchise taxes, ad valorem taxes, severance taxes, capital levy taxes, transfer taxes,
withholding, employment and payroll-related taxes, property taxes and import duties), and includes
interest, additions to tax assessments, fines and penalties with respect thereto.

ARTICLE X

GENERAL PROVISIONS

SECTION 10.01 Notices. All notices and other communications given or made pursuant
to this Agreement shall be in writing and shall be deemed to have been duly given or made as of the
date delivered, mailed or transmitted to the other party’s facsimile number, and shall be effective
upon receipt, if delivered personally, the next business day if sent by reputable overnight express
courier, charges prepaid, or, if mailed, three (3) days after deposit with the United States Postal
Service, certified mail, return receipt requested, postage prepaid, to the Parties at the following
addresses (or at such other address for a Party as shall be specified by like changes of address)
or upon receipt if sent by electronic transmission to the facsimile number specified below
(provided a confirmation copy is sent by reputable overnight express courier, charges prepaid):

If to USPG or NationsHealth:

Glenn Parker, M.D.

NationsHealth, Inc.

13630 NW 8th Street

Suite 210

Sunrise, Florida 33325

Facsimile: 954-903-5008

With a copy to:

Ira J. Coleman, P.A.

McDermott Will & Emery

201 South Biscayne Boulevard

Suite 2200

Miami, Florida 33131-4336

Facsimile: 305-347-6500

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

21

 

Mr. Robert E. Tremain

Chief Operating Officer

NationsHealth, Inc.

13630 NW 8th Street

Suite 210

Sunrise, Florida 33325

Facsimile: 954-903-5252

If to CIGNA:

Ms. Terri A. Swanson

CIGNA HealthCare, S-351

900 Cottage Grove Road

Hartford, Connecticut 06152—2201

Facsimile: 860-226-4410

With a copy to:

Rhonda M. Karlin, Esquire

Senior Counsel

CIGNA HealthCare, S-201

900 Cottage Grove Road

Hartford, Connecticut 06152—2201

Facsimile: 860-226-7222

SECTION 10.02 Headings. The headings contained in this Agreement are for reference
purposes only and shall not affect in any way the meaning or interpretation of this Agreement.

SECTION 10.03 Severability. If any term or other provision of this Agreement is
finally adjudicated by a court of competent jurisdiction to be invalid, illegal or incapable of
being enforced by any Law, all other conditions and provisions of this Agreement shall nevertheless
remain in full force and effect. Upon such determination that any term or other provision is
invalid, illegal or incapable of being enforced, the Parties shall negotiate in good faith to
modify this Agreement , as the case may be, so as to effect the original intent of the Parties as
closely as possible in an acceptable manner to the end that transactions contemplated hereby are
fulfilled to the extent possible.

SECTION 10.04 Entire Agreement. This Agreement (together with any Exhibits and
Schedules hereto and thereto) constitute the entire agreement of the Parties and supersede all
prior agreements and undertakings, both written and oral, between the Parties with respect to the
subject matter hereof. Each Party acknowledges that nothing in this Agreement or any other
materials presented to such Party in connection with the transaction contemplated by this Agreement
constitutes legal or tax advice to such Party. The Parties have consulted such legal and tax
advisors as they, in their sole discretion, have deemed necessary or appropriate in connection with
this Agreement.

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

22

 

SECTION 10.05 Assignment. Any Party may assign its rights and duties hereunder only
to a wholly-owned or wholly-controlled subsidiary or Affiliate; provided, however,
that as a condition to any assignment, the assignor shall remain liable to perform, or to cause its
assignee to perform, all of the assignor’s obligations under this Agreement.

SECTION 10.06 Parties in Interest. This Agreement shall be binding upon and inure
solely to the benefit of each Party and their respective successors and permitted assigns, and
nothing in this Agreement, express or implied, is intended to or shall confer upon any other Person
any right, benefit or remedy of any nature whatsoever under or by reason of this Agreement.

SECTION 10.07 Construction of Terms. Whenever used in this Agreement, a singular
number shall include the plural and a plural the singular. Pronouns of one gender shall include
all genders. References herein to articles, sections, paragraphs, subparagraphs or the like shall
refer to the corresponding articles, sections, paragraphs, subparagraphs or the like of this
Agreement, as the case may be. The words “hereof,” “herein,” and terms of similar import shall
refer to this entire Agreement. Whenever used in this Agreement, the use of the terms “including,”
“included,” “such as,” or terms of similar meaning, shall not be construed to imply the exclusion
of any other particular elements.

SECTION 10.08 No Strict Construction. The language used in this Agreement shall be
deemed to be the language chosen by the Parties to express their mutual intent, and no rule of
strict construction shall be applied against any Party.

SECTION 10.09 Governing Law; Jurisdiction; Waiver of Jury Trial.

(a) Except to the extent that each of the Parties is governed by the Laws of its domiciliary
state, this Agreement shall be construed and enforced in accordance with the internal Laws of the
State of Connecticut.

(b) The jurisdiction and venue for any request, motion or other action for injunctive relief,
specific performance and other equitable relief brought by any Party hereto pursuant to this
Agreement shall properly lie in any federal court of competent jurisdiction located in Hartford,
Connecticut. By execution and delivery of this Agreement, each Party hereto irrevocably submits to
the exclusive jurisdiction of such courts for itself and in respect of its property with respect to
such action. The Parties irrevocably agree that venue would be proper in such court, and hereby
waive any objection that such court is an improper or inconvenient forum for the resolution of such
action. The Parties further agree that the mailing by certified or registered mail, return receipt
requested, of any process required by any such court shall constitute valid and lawful service of
process against them, without necessity for service by any other means provided by statute or rule
of court.

SECTION 10.10 Amendment. This Agreement may not be amended except by an instrument in
writing signed by the Parties, except that in the event that this Agreement or any Exhibit does not
contain a particular provision required by the Laws governing the Part D program, or any provision
of this Agreement or an Exhibit conflicts with such Laws or regulations, then this Agreement and
any Exhibits, as applicable, shall be deemed amended to

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

23

 

comply with the Laws governing the Part D program and any conflicting provision shall be
deemed stricken and such amendment shall be effective immediately upon the date that such Law
becomes effective. Upon a determination that an amendment or modification by CMS to the Part D
program renders this Agreement economically unfeasible for USPG or NationsHealth, the Parties shall
negotiate in good faith to modify this Agreement so as to effect the original intent of the Parties
as closely as possible in an acceptable manner to the end that transactions contemplated hereby are
fulfilled to the extent possible.

SECTION 10.11 Waiver. At any time a Party may (a) extend the time for the performance
of any of the obligations or other acts of another Party, (b) waive any inaccuracies in the
representations and warranties of another Party contained in this Agreement or in any document
delivered pursuant to this Agreement and (c) waive compliance by another Party with any of the
agreements or conditions contained in this Agreement. Any such extension or waiver shall be valid
only if set forth in an instrument in writing signed by the Party or Parties to be bound thereby.
It is agreed that no delay or omission to exercise any right, power or remedy accruing to any
Party, upon any breach, default or noncompliance by any other Party under this Agreement shall
impair any such right, power or remedy, nor shall it be construed to be a waiver of any such
breach, default or noncompliance, or any acquiescence therein, or of or in any similar breach,
default or noncompliance thereafter occurring. It is further agreed that any waiver, permit,
consent or approval of any kind or character on any Party’s part of any breach, default or
noncompliance under this Agreement or any waiver on such Party’s part of any provisions or
conditions of this Agreement must be in writing and shall be effective only to the extent
specifically set forth in such writing. All remedies, either under this Agreement afforded to any
Party shall be cumulative and not alternative.

SECTION 10.12 Counterparts. This Agreement may be executed via facsimile in one or
more counterparts, and by the different Parties hereto in separate counterparts, each of which when
executed shall be deemed to be an original but all of which taken together shall constitute one and
the same agreement.

ARTICLE XI

SERVICING PROCEDURES

SECTION 11.01. Servicing Procedures. Notwithstanding any other provision of this
Agreement, the Parties have agreed for the period commencing May 1, 2006, the servicing procedures
described in Exhibit 11.01 shall be implemented.

IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed as of the date first
written above by their respective officers duly authorized.

SIGNATURES APPEAR ON FOLLOWING PAGE

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

24

 

	 	 	 	 	 
	 	 	UNITED STATES PHARMACEUTICAL GROUP, LLC
	 
	 	 	 	 
	 

	 	By	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Its	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 	 	NATIONSHEALTH, INC.
	 
	 	 	 	 
	 

	 	By	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Its	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 	 	CONNECTICUT GENERAL LIFE INSURANCE COMPANY
	 
	 	 	 	 
	 

	 	By	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Its	 	 
	 

	 	 	 	 

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

25

 

EXHIBIT 1.02

PART D CAPABILITIES

USPG shall establish and maintain throughout the term of this Agreement the necessary systems and
infrastructure in order to perform its obligations under this Agreement in accordance with CMS and
CIGNA requirements reasonably necessary to support the PDP. Specifically, USPG shall establish and
maintain:

	A.	 	Connectivity:

	 	1.	 	to CMS via the *** to and from ***;

	 
	 	2.	 	to CIGNA or its designee to *** to *** for *** and *** to be *** by the ***;

	 
	 	3.	 	to CIGNA to *** and *** and *** as *** and *** to be *** by the ***.

	B.	 	Systems:

	 	1.	 	to *** from *** with *** to *** make *** and *** with *** or its *** to *** to ***;

	 
	 	2.	 	to *** and *** and *** and to *** and *** on *** and *** and ***;

	 
	 	3.	 	to *** and *** to *** by ***;

	 
	 	4.	 	to perform *** and ***:

	 
	 	5.	 	to ***, and *** on ***;

	 
	 	6.	 	to *** and *** of *** to *** with *** and *** by the ***.

	C.	 	Data Management and Reporting Processes:

	 	1.	 	to enable *** to *** its *** to *** as a ***. *** include but are not limited to ***
and call center ***.

	 
	 	2.	 	to enable *** and *** of the *** and *** in Exhibits 1.03 — 1.07 and this
Exhibit 1.02. The Parties acknowledge that the *** described in Exhibit
1.07 pertains to *** and ***. The format, content, and timing of management reports
are to be agreed upon by the Parties.

	D.	 	Sufficient personnel (employed and contracted) to ensure the timely performance of USPG’s
obligations hereunder in a manner that provides Medicare beneficiaries and their
representatives convenient, accessible and accurate service in a courteous, professional
manner, as well as being responsive to ***. All such personnel shall be trained in accordance
with applicable CMS guidance.

	 
	E.	 	Systems and infrastructure in a “hardened” data center on or before the earlier of October 1,
2005, or such other date as CMS requires for testing or otherwise.

	 
	F.	 	Exhibit 5.04, Service Level Requirements, specifies standards of timeliness,
accuracy, and quality that are consistent with, or exceed, the standards that are set forth in
CMS instructions and guidelines and agreed upon monetary penalties and incentives for,
respectively, failing to meet or exceeding, service levels with respect to the services to be
provided by USPG.

	 
	G.	 	A *** and *** after the *** as *** in ***.

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

26

 

EXHIBIT 1.03

MARKETING AND BENEFICIARY COMMUNICATIONS

	A.	 	USPG shall market CIGNA’s PDP in accordance with applicable CMS requirements set forth at 42
C.F.R. § 423.50 and CMS’ Medicare Marketing Guidelines for: Medicare Advantage Plans (MA),
Medicare Advantage Prescription Drug Plans (MA-PDs) Prescription Drug Plans (PDPs), [and] 1876
Cost Plan (issued August 15, 2005, revised November 4, 2005, and any subsequent revisions
thereto) and the marketing program agreed to by USPG, NationsHealth and CIGNA.

	 	1.	 	USPG shall create beneficiary communications materials and facilitate the approval
process with CMS.

	 
	 	2.	 	CIGNA shall review and approve beneficiary communications materials and provide
plan-specific content as required.

	 
	 	3.	 	The parties shall develop a schedule or schedules for the preparation of all marketing
materials for submittal to CMS.

	 
	 	4.	 	The name of CIGNA (or a CIGNA Affiliate) and the name of NationsHealth or USPG will be
displayed on the identification card distributed to Enrollees.

	B.	 	USPG shall provide the following marketing and distribution services:

	 	1.	 	For purposes of this Exhibit 1.03, “marketing materials” include any
informational materials targeted to Medicare beneficiaries which (i) promote the PDP; (ii)
inform Medicare beneficiaries that they may enroll, or remain enrolled in the PDP; (iii)
explain the benefits of enrollment in the PDP, or the rules that apply to Enrollees; and
(iv) explain how Medicare services are covered under the PDP, including conditions that
apply to such coverage.

	 
	 	2.	 	USPG shall market the PDP using a mass media campaign agreed to by USPG, NationsHealth,
and CIGNA, which shall include national television and radio advertisements.

	 
	 	3.	 	USPG shall distribute to prospective Enrollees and employers written marketing
materials regarding the PDP in accordance with the distribution plan agreed to by USPG,
NationsHealth, and CIGNA.

	 
	 	4.	 	USPG shall allocate its marketing resources to include the disabled Medicare
population, Dual Eligibles, as well as beneficiaries age 65 and over, and shall establish
and maintain a system for confirming that enrolled beneficiaries have in fact enrolled in
the PDP and understand the rules applicable to and benefits available under the PDP.

	 
	 	5.	 	Annually and at the time of enrollment, USPG agrees to provide Enrollees information on
the following features of the PDP:

	 	•	 	***;

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

27

 

	 	•	 	***;

	 	•	 	*** for ***;

	 	•	 	*** for ***;

	 	•	 	Types of *** in the ***;

	 	•	 	***;

	 	•	 	***;

	 	•	 	*** Area;

	 	•	 	Current ***;

	 	•	 	*** to *** and *** of the *** or *** in the their *** of any *** on the ***;

	 	•	 	Information about *** and ***;

	 	•	 	Information about ***;

	 	•	 	Information about the *** of *** and *** and

	 	•	 	Information on ***.

	 	6.	 	USPG will maintain a toll-free customer service call center that is open during usual
business hours and provides customer telephone service for potential and current Enrollees
in compliance with standard business practices. USPG agrees to operate the call center in
accordance with the following:

	 	•	 	The call center shall operate *** no *** for those time zones where the PDP is
offered, including the continental United States, Hawaii, and Alaska, unless the
parties agree otherwise;

	 	•	 	*** of all ***;

	 	•	 	The *** of all incoming customer calls shall not exceed ***;

	 	•	 	The *** (i.e. ***) rate shall be set forth in the SLA;

	 	•	 	The call center shall provide thorough information about the PDP’s benefit plans,
including co-payments, deductibles, and network pharmacies;

	 	•	 	The call center shall incorporate procedures for handling customer ***;

	 	•	 	The call center shall provide service to *** and ***;

	 	•	 	The call center shall provide the information described in 5 above. CIGNA will
provide the information within its, or its designee’s, possession to USPG or provide
the requisite tools to enable USPG’s access to such information.

	 	•	 	The call center shall refer appeals and coverage determination issues, provider
inquiries, and potential fraud and abuse matters to CIGNA.

	 	7.	 	USPG shall distribute to Enrollees information jointly developed by the parties
regarding the PDP formularies and tiers, step therapy, PA and dose limits.

	 	8.	 	USPG shall distribute to Enrollees information regarding the coverage determination,
exceptions, grievance and appeals process, which information shall be included in the PDP’s
Evidence of Coverage and outreach materials jointly developed by the parties.

	 	9.	 	USPG shall provide to CIGNA the information necessary for CIGNA’s submissions to CMS
for the CMS comparative website in accordance with the requirements set forth at 42 C.F.R.
§ 423.48.

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

28

 

	C.	 	Additional Obligations of USPG and NationsHealth

	 	1.	 	USPG shall require its employees, agents, and representatives engaged in marketing
CIGNA’s PDP to receive training in CMS’ Medicare marketing instructions and guidelines
before they are permitted to talk with prospective Enrollees. Each such employee, agent,
and representative shall sign a form acknowledging that he or she has received such
training. CIGNA shall have a reasonable period of time within which to review, and comment
on, any training materials.

	 	2.	 	USPG will make available to prospective and current Enrollees only those marketing
materials that have been approved by CIGNA and CMS in accordance with 42 C.F.R. § 423.50.

	 	3.	 	USPG shall report to CIGNA the number of *** in *** or *** and *** and ***. The form,
content and frequency of such reports shall be agreed to by the parties.

	 	4.	 	USPG shall monitor and/or record for later review no less than *** for each USPG ***.
The parties shall agree upon standards against which the quality and accuracy of such
monitored or review/*** will be assessed. USPG shall report the results of its call center
monitoring and review on a quarterly basis, together with any corrective actions taken with
respect to call center personnel who fail to meet the parties’ agreed-upon acceptable
quality levels.

	 	5.	 	USPG shall report to CIGNA the *** for *** and ***. The form, content and frequency of
such reports shall be agreed to by the parties.

	 	6.	 	USPG shall provide call center statistics as specified in CMS’s Final Medicare Part D
Reporting Requirements in sufficient time for CIGNA to provide them to CMS at the times set
forth in Section VIII thereof.

	 	7.	 	USPG shall maintain records and provide support for any CMS or HHS OIG audits of
marketing and call center operations.

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

29

 

EXHIBIT 1.04

ENROLLEE BILLING AND PREMIUM COLLECTION

USPG shall perform the following premium billing and collection services on behalf of CIGNA for
Enrollees in accordance with CMS requirements set forth at 42 C.F.R. § 423.293 and any CMS
guidance, when issued.

1. By the monthly date established in CMS guidelines, USPG shall bill each Enrollee the monthly
premium due under the PDP as communicated by CIGNA to USPG. USPG shall bill for each individual
enrolled in the PDP for that month according to USPG’s enrollment records.

2. USPG shall permit each Enrollee, at the Enrollee’s option, to make premium payment through an
electronic funds transfer mechanism or other means established by CMS.

3. USPG shall be able to allow Enrollees to pay their premium via automatic deductions pursuant to
42 C.F.R. § 422.262(f)(1) and accept such premium payments. USPG shall not bill the Social
Security Administration or the Railroad Retirement Board for such amounts.

4. USPG shall be able to support any supplemental premium billing to and collection from Enrollees.

5. USPG shall instruct Enrollees to submit premiums directly to CIGNA, whether by mail to a post
office box maintained by CIGNA or, if payments are made electronically, to a CIGNA lockbox account.
All premiums otherwise collected by USPG on behalf of CIGNA shall be deposited into a lockbox
account maintained by CIGNA *** of ***.

6. USPG shall update its enrollee records of all premium payments received *** from CIGNA that the
premium payment has been deposited.

7. USPG shall administer the policies and procedures jointly developed by the parties in accordance
with any applicable CMS guidance regarding the collection of delinquent premium payments and
disenrollment of Enrollees for nonpayment. In no event shall an Enrollee be disenrolled without
CMS prior approval.

8. USPG shall be able to identify, collect and remit to CMS any late enrollment penalty amount due
from or on behalf of an Enrollee that is identified by CMS.

9. USPG shall modify the billing for any Enrollee who becomes eligible for or loses eligibility for
Medicaid.

10. USPG shall be able to apply different premium amounts for one or more categories of Enrollees
including low income Enrollees.

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

30

 

EXHIBIT 1.05

ENROLLMENT AND ELIGIBILITY

	A.	 	*** USPG shall establish and maintain an *** that *** with *** and *** and has the *** and
***:

	 	1.	 	*** from ***;

	 
	 	2.	 	*** data for *** that *** their separate ***;

	 
	 	3.	 	*** or *** when *** to *** and *** and *** within two *** of its *** of ***;

	 
	 	4.	 	Generate *** for *** that *** in *** of ***;

	 
	 	5.	 	Provide *** to *** and other *** of their ***;

	 
	 	6.	 	*** and *** in any *** and ***;

	 
	 	7.	 	Administer an *** at the ***: (a) for *** through ***; and (b) for *** and ***: ***
through *** of each *** for the ***;

	 
	 	8.	 	*** for *** of other *** of the *** of such other ***, and other *** in ***;

	 
	 	9.	 	*** and *** for *** of *** other *** that an *** for *** in *** of *** of *** required
of *** by ***; and,

	 
	 	10.	 	*** and *** by *** for the purposes of *** and *** in accordance with *** in *** and
any standards *** in the ***.

	B.	 	Enrollment Forms and Materials. USPG shall:

	 	1.	 	Jointly develop with CIGNA enrollment forms that satisfy CMS requirements and are
approved by CMS;

	 	2.	 	Within the time period required by *** of *** from *** of an *** to *** with the ***:

	 	•	 	include the ***,

	 	•	 	exclude the *** and ***, and *** an *** number, and

	 	•	 	include the *** of *** with ***;

	C.	 	***. USPG shall:

	 	1.	 	Administer an *** jointly developed with *** that satisfies CMS guidelines ***:

	 	•	 	*** applying for enrollment *** PDP within timeframes specified by CMS ***;

	 	•	 	initiating appropriate follow up with beneficiaries who have *** of *** of such ***
or such period *** in the ***; and

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

31

 

	 	•	 	making *** effective according to the *** associated with the *** in which the ***.

	 	2.	 	Within *** of *** of a *** the ***. Notify applicants of the acceptance or denial of
their enrollment application within *** of *** of *** of such *** or ***.

	 	3.	 	Notify each *** to or at the time of ***, of ***and disclosures of the ***, and the ***
and *** with respect to such ***.

	 	4.	 	Administer a process to *** that *** in the *** and *** the ***. Such process shall
involve a *** by the ***. As the Parties may so agree, *** make a “***” call within such
time and using such script as jointly agreed to by the Parties.

	 	5.	 	Accept enrollments from beneficiaries.

	 	6.	 	Enroll Medicare beneficiaries who are eligible for Part D and reside in the PDP’s
Service Area during allowable enrollment periods according to CMS requirements with no
underwriting;

	 	7.	 	To the extent practicable, not enroll any beneficiary who is already enrolled in a Part
D plan or, who is identified as a member of a Medicare Advantage plan (other than a private
fee-for-service plan that does not provide qualified prescription drug coverage or an MSA
plan) and provide *** of the *** and the reason[s] therefor.

	 
	 	8.	 	Not enroll beneficiaries except during allowable enrollment periods specified by CMS.

	 
	 	9.	 	Accept and process any *** by *** of *** and *** to enroll in a Part D plan.

	 
	 	10.	 	Develop policies and procedures for addressing beneficiary requests for a and verifying
a beneficiary’s eligibility for a ***.

	 
	 	11.	 	Receive enrollment forms from Enrollees and retain such forms in paper form.

	 
	 	12.	 	*** the *** in accordance with *** of this Agreement.

	 
	 	13.	 	Agree in the *** and *** for the foregoing functions.

	D.	 	Maintenance of Enrollment. An Enrollee shall remain enrolled in the PDP until one of
the following occurs:

	•	 	The individual *** in *** or ***;

	 
	•	 	The individual *** from the ***;

	 
	•	 	The individual is *** from the ***;

	 
	•	 	The PDP is *** within the *** in which the individual ***; or

	 
	•	 	*** a *** in another *** in accordance with ***.

	E.	 	Disenrollment Management. USPG shall administer the PDP’s disenrollment process in
accordance with policies and procedures jointly developed by the parties and in accordance
with CMS disenrollment procedure requirements.

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

32

 

	 	1.	 	***. USPG will *** and *** from ***:

	 	(i)	 	Submit a *** to *** within ***;

	 
	 	(ii)	 	Provide the *** with a *** of *** as

	 
	 	(iii)	 	File and retain *** requests for the period specified in ***.

	 	2.	 	***.

	 	(i)	 	USPG shall *** and *** of *** in accordance with applicable CMS requirements.
Except as permitted by CMS regulations, USPG shall not *** the ***, or *** or in ***,
or by any *** or ***.

	 	(ii)	 	***. USPG shall *** an *** in any of the following circumstances: (a) Any ***
is not *** on a ***, as specified under paragraph ***; or (b) The *** has ***, as
specified under ***.

	 	(iii)	 	***. USPG shall *** an *** in any of the following circumstances: (a) The ***;
(b) The ***; (c) ***; (d) *** is terminated by *** (e) ***, as determined by ***, to
the *** or *** that the individual has or expects to *** for ***. USPG shall *** with
the *** through ***.

	 
	 	(iv)	 	***. USPG shall prepare a *** of ***.

	 	3.	 	***.

	 	(i)	 	If the *** is for any of the reasons specified in Sections B, C(i) or (iv) of
this section (that is, other than *** or *** of ***) USPG shall give the *** of the ***
is *** to *** the *** to ***.

	 
	 	(ii)	 	*** for reasons specified in Sections B, C(i) and (iii) shall:

	 	•	 	Be provided to the individual before submission of the disenrollment notice to
CMS; and

	 
	 	•	 	Include an explanation of ***.

	 	4.	 	***. USPG will *** in the event of a *** of the *** and *** for *** in accordance with
***.

	 
	 	5.	 	Agree in the *** to *** and *** standards for ***.

	F.	 	Maintenance and Reporting of Data. USPG shall provide the data required in *** in
the *** and at the *** therein. USPG shall maintain *** to *** the *** of such *** or the
***.

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

33

 

EXHIBIT 1.06

ENROLLEE INQUIRIES AND GRIEVANCE PROCESSING

USPG shall be responsible for communications from Enrollees as set forth herein. USPG shall
administer the PDP’s enrollee inquiries grievance procedures in accordance with CMS requirements
set forth at 42 C.F.R. § 423.564 and Chapter 18 of the Prescription Drug Benefit Manual—Part D
Enrollee Grievances, Coverage Determinations, and Appeals. For purposes hereof, a “grievance” is
any complaint or dispute, other than one that involves a coverage determination, expressing
dissatisfaction with any aspect of CIGNA’s or any of its subcontractors’ and providers’ operations,
activities, or behavior, regardless of whether remedial action is requested. The grievance
procedure is separate and distinct from the appeal procedure. The PDP’s appeal procedure shall be
the sole responsibility of CIGNA. An “inquiry” is any communication from an Enrollee that is not a
grievance or an appeal. An “Enrollee” includes an Enrollee’s representative. All communications
from providers shall be directed to CIGNA.

	A.	 	General Requirements

	 	1.	 	USPG will develop protocols and definitions sufficient to enable its Customer Service
Representatives (“CSRs”) accurately to distinguish and classify Enrollee inquiries,
grievances (including types of grievances), and appeals. Such protocols and definitions
are subject to review and comment by CIGNA.

	 	2.	 	USPG will maintain an accuracy rate to be determined in the SLA in its identification
and classification of inquiries, grievances, and appeals.

	 	3.	 	USPG will audit for the accuracy of its identification and classification of inquiries,
grievances, and appeals based on audit frequencies and sample sizes agreed upon by the
parties.

	 	4.	 	CIGNA will provide, or provide access to, any information within its, or its
designee’s, control necessary to USPG to perform the services described herein.

	 	5.	 	The Parties shall develop processes which will enable USPG to refer all communications
from providers to CIGNA and all Enrollee communications about mail order prescriptions
covered under Part D to CIGNA.

	B.	 	Enrollee Inquiries

	 	1.	 	Telephone Inquiries. USPG shall handle all telephonic inquiries by Enrollees
or Enrollee representatives in a timely, courteous, professional, and culturally competent
manner.

	 	(a)	 	The service levels for timeliness and accuracy in responding to such inquiries
shall be the same as set forth in Exhibit 1.03 of this Agreement.

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

34

 

	 	(b)	 	USPG shall maintain and report data on telephonic inquiries in the formats and
at the times set forth in Section VIII of CMS’s Final Medicare Part D Reporting
Requirements. USPG shall maintain sufficient records to support the accuracy of such
reported data in the event of an audit by CMS or the HHS OIG.

	 	2.	 	Written Inquiries. USPG shall be responsible for responding to all written
inquiries from Enrollees or Enrollee representatives in a timely, accurate, professional,
and culturally competent manner. Written inquiries include any correspondence that has
been mailed, telecopied, or e-mailed.

	 	(a)	 	USPG will implement procedures for date stamping, marking for identification,
and tracking all written Enrollee inquiries. Date stamping of a percentage specified
in the SLA of such inquiries will be accomplished within *** of their *** of *** shall
be *** of their ***.

	 	(b)	 	Written acknowledgement of a written inquiry shall be mailed within 7 days of
USPG’s receipt of the inquiry unless a different period is established in the SLA.

	 	(c)	 	The SLA shall specify written disposition of a specific percentage of all
written inquiries shall be mailed *** of USPG’s *** of the *** of *** of *** shall be
*** within *** of *** of the ***.

	 	(d)	 	The minimum acceptable accuracy rate of USPG’s written dispositions shall be
identified as a percentage specified in the SLA.

	 	(e)	 	USPG will implement a process for auditing and monitoring the timeliness and
accuracy of USPG disposition of written inquiries based on audit frequencies and sample
sizes to be agreed upon by the parties. USPG will provide, on a quarterly basis,
reports to CIGNA of USPG’s audits, together with any corrective action taken to remedy
any non-compliance with the timeliness and accuracy levels set forth herein.

	C.	 	Grievances

	 	1.	 	USPG will administer a process jointly developed with CIGNA that is designed to track
and address Enrollees’ grievances that includes appropriate timelines, policies and
procedures, as well as definitions and protocols for identifying the different types of
grievances identified in 42 CFR § 423.564 and Section V of the Final Medicare Part D
Reporting Requirements.

	 	2.	 	USPG will train its staff and any subcontractors involved in the grievance procedure on
such policies and procedures in accordance with 42 C.F.R. § 423.564.

	 	3.	 	USPG will accept grievances from Enrollees by telephone and in writing (including
facsimile and in whatever other form CMS requires CIGNA to accept grievances, and reject
any that are untimely under 42 CFR § 423.524(d)(2).

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

35

 

	 	4.	 	Fraud and Abuse grievances, as defined in Section V of the Final Medicare Part D
Reporting Requirements, shall be referred to CIGNA for disposition.

	 	5.	 	USPG shall notify the Enrollee of the grievance decision as expeditiously as the case
requires, based on the Enrollee’s health status, but no later than *** after the date USPG
receives the oral or written grievance; provided that USPG may extend the *** timeframe by
up to *** if the Enrollee requests the extension or if USPG justifies a need for additional
information and documents how the delay is in the interest of the Enrollee. When USPG
extends the deadline, it shall immediately notify the Enrollee in writing of the reason(s)
for the delay.

	 	6.	 	USPG shall inform the Enrollee of the disposition of the grievance in accordance with
the following procedures:

	 	•	 	All *** in *** must be ***.

	 	•	 	*** may be *** to either *** or in ***, unless the *** a ***.

	 	•	 	*** of *** must be *** to in ***.

	 	7.	 	USPG shall respond to an Enrollee’s grievance *** if the complaint involves a refusal
by CIGNA to grant an Enrollee’s request for an expedited coverage determination under 42
C.F.R. § 423.570 or an expedited redetermination under 42 C.F.R. § 423.584, and the
Enrollee has not yet purchased or received the drug that is in dispute.

	 	8.	 	USPG will maintain, and provide upon request by CIGNA or CMS, access to records on all
grievances received both orally and in writing, that includes:

	 	•	 	Date of receipt of the grievance

	 	•	 	Mode of receipt of grievance (i.e. fax, telephone, letter, etc.)

	 	•	 	Person or entity that filed the grievance

	 	•	 	Subject of the grievance

	 	•	 	Final disposition of the grievance

	 	•	 	Date the Enrollee was notified of the disposition.

	 	9.	 	USPG shall maintain and report data or grievances required in Section V of the Final
Medicare Part D Reporting Requirements in the formats and at the times specified therein.
USPG shall maintain sufficient records to support the accuracy of such data in the event of
an audit by CMS or the HHS Office of Inspector General.

	D.	 	Appeals

The parties shall jointly develop procedures for transmitting to CIGNA, as expeditiously as
possible, any appeals received by USPG.

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

36

 

Exhibit 10.2

EXHIBIT 1.07

DETERMINATION OF COMPENSATION AND SERVICES RELATED TO THE 2007

AND SUBSEQUENT PLAN YEARS

SERVICES

USPG shall provide to CIGNA the services enumerated in this Exhibit 1.07. The services shall be
performed, at a minimum, consistent with the timeliness, accuracy and quality standards set forth
in CMS instructions and guidelines, provided, however, that the Parties may agree to standards in
addition to, or in excess of, those established by CMS. In the event of a conflict between any
provision of this Exhibit 1.07 and any provision of Exhibit 5.04 the latter shall control.

The services are categorized by major business process and process in Table 1.07 and further
described below. Each specific service is either included in the fee listed in the Monthly Fee
Schedule which is defined below in this Exhibit 1.07 or is available at CIGNA’s option at an
additional charge.

Key assumptions for services included in the fee in the Monthly Fee Schedule are as follows:

Marketing/Sales and Enrollment Processing:

*** in the *** represent steady-state operations over the course of the year. Auto-assigned
enrollment and CMS web-based enrollment are included in the ***. In addition, up to *** are *** in
the ***. Facilitated enrollments and premium billing and collections for CMS and for State
Pharmaceutical Assistance Programs implemented on or before May 1, 2006, specifically CT, MD, and
ME, are included in the ***. All disenrollments are *** in the ***. Up to *** outbound *** are
*** in the ***.

***, including *** to *** and *** beyond that incorporated in the ***, for example, *** an ***,
will be *** or *** and documented in a Statement of Work (refer to Compensation for Optional
Services).

Post-enrollment Service

*** in the *** represent steady-state operations over the course of the year.

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

37

 

 *** will be *** on a *** or *** and documented in a Statement of Work (refer to Compensation for
Optional Services).

Reporting

*** in the *** represent steady-state operations over the course of the year.

Table 1.07. Services by Major Business Process.

	 	 	 	 	 	 	 
	 	 	 	 	 	 	Service
	 	 	 	 	 	 	Included
	 	 	 	 	 	 	in
	 	 	 	 	 	 	Monthly
	Major Business	 	 	 	 	 	Fee or
	Process	 	Process	 	Service	 	Optional
	Marketing/Sales

	 	Enrollment Call Center
	 	Incoming calls related to information requests and/or
resulting enrollment
	 	***
	 

	 	 	 	Outgoing calls related to information requests and/or
resulting enrollment
	 	***
	 

	 	 	 	Outbound Call Marketing Campaign — both live and IVR
	 	***
	 

	 	 	 	Call Center Operations
	 	***
	 

	 	Retention Campaign
	 	Outbound calling campaigns to drive member retention.
Up to 3 IVR campaigns per year are included in the
Monthly Base Fee.
	 	***
	 

	 	Marketing Campaign
	 	TV, radio, direct mail, print, & event — Includes
creative, production, execution and measurement
	 	***
	 

	 	Fulfillment
	 	Mailing of plan promotional materials — postcards,
brochures, mailers, etc.
CMS Plan documents — mailing of Information
Enrollment Guide — CMS Enrollment Form (Exhibit 1)
and Summary of Benefits
***and *** to ***
	 	***

***

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

38

 

	 	 	 	 	 	 	 
	 	 	 	 	 	 	Service
	 	 	 	 	 	 	Included
	 	 	 	 	 	 	in
	 	 	 	 	 	 	Monthly
	Major Business	 	 	 	 	 	Fee or
	Process	 	Process	 	Service	 	Optional
	Enrollment

Processing

	 	Enrollment Processing
	 	Processing of phone and/or paper applications
	 	***
	 

	 	 	 	Downloading and processing Web enrollment
	 	***
	 

	 	 	 	Receiving and processing of CMS Auto-enrollee and
facilitated enrollment files
	 	***
	 

	 	 	 	Follow-up and completion of incomplete enrollment
applications
	 	***
	 

	 	Systems Availability
	 	Hours of availability — In support of phone enrollment
	 	***
	 

	 	Fulfillment resulting
from enrollment request -
Prior to CMS processing
	 	Mailing of Exhibit 2 — Acknowledge Receipt of
Completed Enrollment Letter
	 	***
	 

	 	 	 	Mailing Exhibit 6 — PDP Denial of Enrollment (where
applicable)
	 	***
	 

	 	File Transfers
	 	Sending file of Enrollment records to CMS
	 	***
	 

	 	 	 	Sending Fulfillment records to Fulfillment Vendor
	 	***
	 

	 	 	 	Sending Eligibility records to CIGNA and ARGUS
	 	***
	Post-Enrollment

Service

	 	Member Service Call Center
	 	All incoming calls related to member services
	 	***
	 

	 	 	 	Call Center Operations
	 	***
	 

	 	Processing of Enrollee
Initiated Changes and
submission of changes to
CMS
	 	Eligibility/Enrollment maintenance (e.g. change of
address, disenrollment or cancellation requests,
etc.) in accordance with PDP Eligibility, Enrollment
and Disenrollment Guidance.
	 	***
	 

	 	Processing as a result of
CMS TRR
	 	NH systems processing and reconciling the CMS
Transaction Reply File (TRR) e.g. enrollment
approvals, eligibility updates, etc.
	 	***
	 

	 	 	 	Sending eligibility updates to CIGNA and ARGUS
	 	***

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

39

 

	 	 	 	 	 	 	 
	 	 	 	 	 	 	Service
	 	 	 	 	 	 	Included
	 	 	 	 	 	 	in
	 	 	 	 	 	 	Monthly
	Major Business	 	 	 	 	 	Fee or
	Process	 	Process	 	Service	 	Optional
	 

	 	 	 	Sending CMS Plan Payment Report, TRR and MMR records
to CIGNA
	 	***
	 

	 	 	 	Sending fulfillment records to Fulfillment Vendor
	 	***
	 

	 	Fulfillment as a result
of CMS TRR File
processing (e.g.
responses for records
sent to CMS and CMS
reported eligibility
changes)
	 	Mailing of Welcome Kit — including ID Card, evidence
of coverage, etc. for approved enrollees
***and *** to ***
	 	***
	 

	 	 	 	Mailing of all CMS mandated Exhibits per PDP
Eligibility, Enrollment and Disenrollment Guidelines
(excluding those items included in the Welcome kit)
	 	***
	 

	 	Other Fulfillment
	 	Processing and mailing of annual COB Survey
	 	***
	 

	 	 	 	Upon member request, processing and mailing of:
Caregiver forms, HIPAA Privacy Forms, Formularies,
Pharmacy Directories, Summary of Benefits, Credit
Card/ACH forms, Disenrollment forms, Claim forms, EOB
copies.
	 	***
	 

	 	Systems Availability
	 	In support of member services hours of operation
	 	***
	 

	 	Enrollee written inquiries
	 	Responding to inquiries from enrollees in writing and
consistent with CMS requirements
	 	***
	 

	 	CMS Complaint
	 	Responding to CMS caseworker reported complaints and
maintenance of CMS complaint log
	 	***
	 

	 	Handling of Grievances
	 	Accept and respond to member grievances received via
telephone and in writing
	 	***
	 

	 	Premium Billing and
Collection
	 	For members who choose direct bill, produce and mail
invoices monthly.
	 	***

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

40

 

	 	 	 	 	 	 	 
	 	 	 	 	 	 	Service
	 	 	 	 	 	 	Included
	 	 	 	 	 	 	in
	 	 	 	 	 	 	Monthly
	Major Business	 	 	 	 	 	Fee or
	Process	 	Process	 	Service	 	Optional
	 

	 	 	 	Collect, process and apply member payments monthly.
	 	***
	 

	 	 	 	Provide members with payment options other than
direct bill including recurring or one-time credit
card and recurring ACH. Process and reconcile
transactions monthly.
	 	***
	 

	 	 	 	Bill and invoice other payors participating or
contracted with CIGNA for the CIGNATURE Rx program
including but not limited to State Pharmaceutical
Assistance Programs. Assumes other payors use
current processes and formats.
	 	***
	 

	 	 	 	Collect, process and apply payments and adjustments
from other payors participating or contracted with
CIGNA for the CIGNATURE Rx program including but not
limited to State Pharmaceutical Assistance Programs.
Assumes other payors use current processes and
formats.
	 	***
	 

	 	 	 	Create billing records for payors not invoiced
including but not limited to CMS, SPAPs, SSA, etc.
	 	***
	 

	 	 	 	Collect, process and apply payments and adjustments
from CMS including but not limited to (low income
payments, SSA withholding, etc.)
	 	***
	 

	 	 	 	Process refunds for members and other payors as
necessary.
	 	***
	 

	 	 	 	Perform collections activities for overdue premium
including sending appropriate letters and exhibits as
mandated by CMS.
	 	***

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

41

 

	 	 	 	 	 	 	 
	 	 	 	 	 	 	Service
	 	 	 	 	 	 	Included
	 	 	 	 	 	 	in
	 	 	 	 	 	 	Monthly
	Major Business	 	 	 	 	 	Fee or
	Process	 	Process	 	Service	 	Optional
	 

	 	 	 	Reconcile payment and refund activity monthly and
perform necessary follow-up with payors, including
but not limited to CMS, SPAPs, and financial
institutions, to resolve discrepancies and
reconciling items.
	 	***
	 

	 	 	 	Provide monthly data feeds for billed premium and
cash applied and unapplied to CIGNA with control
reports.

Provide monthly reporting including:

Cash Payment reconciliations with aging of
reconciling items.

Uninvoiced members with estimated amounts and
appropriate aging
Accounts Receivable and Paid-In-Advance Reporting
with appropriate Aging.
	 	***
	 

	 	 	 	Support external audits including but not limited to
CMS and state agencies. Support may include
supplemental reporting, access to books and records.
	 	***
	 

	 	 	 	Maintain transaction level detail and history for a
10 year period consistent with CMS requirements.
	 	***
	Reporting

	 	Reporting to CMS Per PDP
Final Reporting
Requirements
	 	USPG shall maintain and report call center statistics
and data on telephonic inquiries as specified in
Section VIII of CMS’s Final Medicare Part D Reporting
Requirements, enrollment and disenrollment data as
specified in Section 1 of CMS’s Final Medicare Part D
Reporting Requirements, and grievances data as
specified in Section V of CMS’s Final Medicare Part D
Reporting Requirements in sufficient time for CIGNA
to provide them to CMS at the times set forth in
CMS’s Final Medicare Part D Reporting Requirements.
USPG
	 	***

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

42

 

	 	 	 	 	 	 	 
	 	 	 	 	 	 	Service
	 	 	 	 	 	 	Included
	 	 	 	 	 	 	in
	 	 	 	 	 	 	Monthly
	Major Business	 	 	 	 	 	Fee or
	Process	 	Process	 	Service	 	Optional
	 

	 	 	 	shall maintain sufficient records to support the
accuracy of such reported data in the event of an
audit by CMS or the HHS OIG.	 	 
	 

	 	Management Information to
CIGNA
	 	Standardized program reports including but not
limited to those in support of monitoring SLA
metrics. USPG shall report to CIGNA the average hold
times for calls, call abandonment rates, and related
statistics. The format, content, and timing of
management reports are to be agreed upon by the
Parties.
	 	***

The Services shall be performed with the following expectations:

Marketing/Sales: Enrollment Call Center and Post-Enrollment Service: Member Service Call Center

	 	1.	 	USPG shall *** and *** to include the ***, as well as ***, and shall establish and
maintain a process for confirming that *** and *** and benefits available under the PDP.

	 
	 	2.	 	USPG will maintain a *** for *** and *** in compliance with standard business practices.
USPG agrees to operate the call center in accordance with the following:

	 	•	 	The call center shall provide thorough information about the PDP’s benefit plans,
including co-payments, deductibles, and network pharmacies. Specifically, the call center
shall provide the information described below. CIGNA will provide the information within
its, or its designee’s, possession to USPG or provide the requisite tools to enable
USPG’s access to such information.

	 	•	 	***;

	 
	 	•	 	Enrollee ***;

	 
	 	•	 	Potential for ***;

	 
	 	•	 	*** for ***;

	 
	 	•	 	*** in the ***;

	 
	 	•	 	***;

	 
	 	•	 	Premiums;

	 
	 	•	 	***;

	 
	 	•	 	***;

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

43

 

	 	•	 	*** or change in the ***;

	 
	 	•	 	Information about ***;

	 
	 	•	 	Information about ***;

	 
	 	•	 	Information about the *** and ***; and

	 
	 	•	 	Information on ***.

	 	•	 	The call center shall incorporate procedures for handling customer complaints;

	 
	 	•	 	The call center shall provide *** and ***;

	 
	 	•	 	The call center shall *** and ***, ***, and *** and *** to ***

	 	3.	 	USPG shall ***, ***, and *** in marketing CIGNA’s PDP to *** and ***. Each such ***,
***, and ***. CIGNA shall have a reasonable period of time within which to review, and
comment on, any ***.

	 
	 	4.	 	USPG will make available to prospective and current Enrollees *** and ***.

	 
	 	5.	 	USPG shall maintain records and provide support for any ***.

Enrollment Processing and Post-Enrollment Service

	A.	 	***. USPG shall establish and maintain an ***, *** with *** and ***, and has the ***:

	 	1.	 	*** status data from ***;

	 
	 	2.	 	Generate ***;

	 
	 	3.	 	Notify *** when *** changes occur to *** and ***;

	 
	 	4.	 	Generate *** that *** in support of *** processing;

	 
	 	5.	 	Provide *** and other ***;

	 
	 	6.	 	Accept *** and *** enrollments, including ***, ***, ***, and ***;

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

44

 

	 	7.	 	Administer an annual enrollment period at the following times: (a) for contract year
2006: November 15, 2005 through May 15, 2006; and (b) for contract year 2007 and thereafter:
November 15 through December 31 of each year for the upcoming contract year;

	 
	 	8.	 	Support ***, enrollees of ***, and other ***;

	 
	 	9.	 	Collect and exchange information for *** regarding other *** in support of ***; and,

	 
	 	10.	 	Collect and transmit data elements specified by *** for the purposes of *** and *** in
accordance with *** and any standards *** in the ***.

	C.	 	Enrollment Process. USPG shall:

	 	1.	 	Administer an enrollment process jointly developed with CIGNA that satisfies CMS
guidelines and that includes:

	 	•	 	communicating with beneficiaries who are applying for enrollment in the PDP within ***;

	 
	 	•	 	initiating appropriate *** in the ***; and

	 
	 	•	 	making enrollments effective according to the effective date policy associated with
the enrollment period in which the enrollment is received.

	 	2.	 	Notify each Enrollee prior to or at the time of enrollment, of *** of the ***, and the
*** and *** with respect to such ***.

	 
	 	3.	 	Administer a process to confirm that beneficiaries have enrolled in the PDP and ***.
Such process shall involve a ***. As the Parties may so agree, USPG shall *** and/or make a
*** time and using such *** to by the Parties.

	 
	 	4.	 	Enroll Medicare beneficiaries who are eligible for Part D and reside in the PDP’s Service
Area during allowable enrollment periods *** with no ***;

	 
	 	5.	 	To the extent practicable, not *** or, *** of a *** and provide *** of the *** and the
reason[s] therefor.

	 
	 	6.	 	Not enroll beneficiaries except during allowable enrollment periods specified by CMS.

	 
	 	7.	 	Develop policies and procedures for addressing *** for a *** and verifying a *** for a
***.

	 
	 	8.	 	Receive enrollment forms from Enrollees and retain such forms in ***.

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

45

 

	 	9.	 	*** in accordance with Section 9(b) of this Agreement.

	D.	 	Maintenance of Enrollment. An *** of the ***:

	 	•	 	The individual ***;

	 
	 	•	 	The individual ***;

	 
	 	•	 	The individual is ***;

	 
	 	•	 	The PDP is *** within the *** in which the ***; or

	 
	 	•	 	CMS enrolls a *** in *** in accordance with ***.

	E.	 	Disenrollment Management. USPG shall administer the PDP’s disenrollment process in
accordance with policies and procedures jointly developed by the parties and in accordance
with CMS disenrollment procedure requirements.

	 	1.	 	***. USPG will accept and process *** from *** as specified by CMS. USPG will:

	 	(i)	 	Submit a *** within ***;

	 
	 	(ii)	 	Provide the *** with a *** as CMS determines and approves; and

	 
	 	(iii)	 	File and retain *** for the period specified in ***.

	 	2.	 	***.

	 	(i)	 	USPG shall initiate and process *** in accordance with applicable ***. Except as
***, USPG shall not***, or by any *** or *** or ***.

	 
	 	(ii)	 	***. USPG shall *** in any of the following circumstances: (a) Any ***, as
specified under paragraph (d)(1) of this section; or (b) The ***, as specified under
paragraph (d)(2) of this section.

	 
	 	(iii)	 	***. USPG shall *** in any of the following circumstances: (a) The ***; (b) The
***; (c) ***; (d) *** or by *** or through ***; and (e) The individual ***, as determined
by ***, to the *** or USPG that the individual has or expects to ***. USPG shall ***
accordance with the procedures for *** set forth at ***.

	 
	 	(iv)	 	***. USPG shall prepare a *** to ensure *** from *** for *** enrollees.

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

46

 

	 	3.	 	***.

	 	(i)	 	If the *** is for any of the reasons specified in Sections B, C(i) or (iv) of this
section (that is, other than *** USPG shall give the individual *** with an *** pursuant
to *** and any ***.

	 
	 	(ii)	 	*** for *** in Sections B, C(i) and (iii) shall:

	 	•	 	Be provided to the individual before *** of the ***; and

	 
	 	•	 	Include an *** of the *** under the PDP’s ***.

	 	4.	 	***. USPG will notify *** in the event of a *** of the *** and *** for *** under Part D
in accordance with Part ***.

Post-Enrollment Service: Enrollee ***

USPG shall perform the following *** on behalf of CIGNA for Enrollees in accordance with CMS
requirements set forth at *** and any CMS guidance, when issued.

	 	1.	 	By the ***, USPG shall *** under the PDP. USPG shall *** for that *** according to
USPG’s enrollment records.

	 
	 	2.	 	USPG shall permit each Enrollee, at the Enrollee’s option, to *** or other ***.

	 
	 	3.	 	USPG shall be able to allow Enrollees to *** and ***. USPG shall not *** or the *** for
such ***.

	 
	 	4.	 	USPG shall be able to support *** to and *** from ***.

	 
	 	5.	 	USPG shall instruct Enrollees to ***, whether by *** or, if ***, ***. All *** by USPG on
behalf of CIGNA shall be *** by CIGNA within *** by USPG.

	 
	 	6.	 	USPG shall update its enrollee records of all ***.

	 
	 	7.	 	USPG shall administer the policies and procedures jointly developed by the parties in
accordance with any applicable CMS guidance regarding the *** and ***. In no event shall an
Enrollee *** without ***.

	 
	 	8.	 	USPG shall be able to identify, *** and *** any *** or on behalf of an Enrollee that is
identified by ***.

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

47

 

	 	9.	 	USPG shall modify the ***or or loses ***.

	 
	 	10.	 	USPG shall be able to *** for one or more categories of Enrollees including ***
Enrollees.

Post-Enrollment Service: ***

USPG shall be responsible for communications from Enrollees as set forth herein. USPG shall
administer the *** procedures in accordance with CMS requirements set forth at *** Part D ***, and
***. For purposes hereof, a ***, other than one that involves a *** with any aspect of ***,
regardless of whether ***. The *** is separate and distinct from the ***. The PDP’s *** shall be
the sole responsibility of CIGNA. An “inquiry” is any communication from an Enrollee that is not a
***. An “Enrollee” includes an Enrollee’s representative. All communications from providers shall
be directed to CIGNA.

	A.	 	General Requirements

	 	1.	 	USPG will develop protocols and definitions sufficient to enable its Customer Service
Representatives (“CSRs”) accurately to distinguish and classify Enrollee ***. Such
protocols and definitions are subject to review and comment by CIGNA.

	 
	 	2.	 	CIGNA will provide, or provide access to, any information within its, or its designee’s,
control necessary to USPG to perform the services described herein.

	 
	 	3.	 	The Parties shall develop processes which will enable USPG to refer communications from
providers to CIGNA and Enrollee communications about mail order prescriptions covered under
Part D and dispensed by ***.

	B.	 	Enrollee Inquiries

	 	1.	 	Telephone Inquiries. USPG shall handle all telephonic inquiries by Enrollees or
Enrollee representatives in a timely, courteous, professional, and culturally competent
manner.

	 
	 	2.	 	Written Inquiries. USPG shall be responsible for responding to all written
inquiries from Enrollees or Enrollee representatives in a timely, accurate, professional,
and culturally competent manner. Written inquiries include any correspondence that has been
mailed, telecopied, or e-mailed.

	C.	 	***

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

48

 

	 	1.	 	*** will administer a process jointly developed with CIGNA that is designed to track and
address Enrollees’ ***, as well as definitions and protocols for *** Medicare Part D ***.

	 
	 	2.	 	USPG will train its staff and any subcontractors involved in the *** procedure on such
policies and procedures in accordance with ***.

	 
	 	3.	 	USPG will accept *** from Enrollees by telephone and in writing (including facsimile and
in whatever other form CMS requires CIGNA to accept ***, and ***.

	 
	 	4.	 	*** Medicare Part D ***, shall be referred to CIGNA for disposition.

	 
	 	5.	 	USPG shall notify the Enrollee of the *** as the case requires, based on the Enrollee’s
health status, but no later than *** after the date USPG receives the ***; provided that
USPG may extend the *** timeframe *** if the Enrollee requests the extension or if USPG
justifies a need for additional information and documents how the delay is in the interest
of the Enrollee. When USPG extends the deadline, it shall immediately notify the Enrollee
in writing of the reason(s) for the delay.

	 
	 	6.	 	USPG shall inform the Enrollee of the disposition of the *** in accordance with the
following procedures:

	 	•	 	All ***.

	 	•	 	*** may be *** or in ***, unless the ***.

	 	•	 	*** must be ***.

	 	7.	 	USPG shall respond to an Enrollee’s *** if the *** involves a refusal by CIGNA to grant
an Enrollee’s request for an expedited coverage determination under *** or an expedited ***,
and the Enrollee has not yet ***.

	 
	 	8.	 	USPG will maintain, and provide upon request by CIGNA or CMS, access to records on all
*** received both orally and in writing, that includes:

	 	•	 	Date of receipt of the grievance

	 
	 	•	 	Mode of receipt of *** (i.e. verbal or written)

	 
	 	•	 	Person or entity that ***

	 
	 	•	 	Subject of the ***

	 
	 	•	 	Final disposition of the ***

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

49

 

	 	•	 	Date the Enrollee was notified of the disposition.

	D.	 	Appeals

The parties shall jointly develop procedures for transmitting to CIGNA, as expeditiously as
possible, any appeals received by USPG.

COMPENSATION

CIGNA’S PAYMENT OF NATIONSHEALTH’S FEES.

At the conclusion of each month, NationsHealth shall within a reasonable time invoice CIGNA for the
amount due NationsHealth. CIGNA shall pay NationsHealth all undisputed amounts within fifteen (15)
days of the receipt of such invoice. To properly dispute an amount of an invoice, CIGNA shall
notify NationsHealth in writing and give its good faith reasons for disputing the amount of the
invoice and any documentation to support its position.

	A.	 	DEFINITIONS

Each of the following shall be as finally determined by CIGNA for applicable periods:

“Base Fees Due NationsHealth” means the sum of the Monthly Fees for the current month and the
previous eleven months.

“Membership” means the number of PDP Enrollees effective in the month as reported by CMS
(including restatements) to which NationsHealth is providing Services.

“Monthly Fees” means the applicable amount from the Monthly Fee Schedule of this Exhibit based
on the monthly Membership as reported by CMS (including restatements).

	B.	 	Calculation of Amount Due NationsHealth

The monthly amount due NationsHealth will be calculated as follows:

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

50

 

	 	 	 	a.) Base Fees Due NationsHealth

	 
	 	 	 	b.) Less: Amounts paid by CIGNA to NationsHealth for Base Fees Due NationsHealth for the
previous eleven months

	 
	 	 	 	c.) Plus: Any unpaid amounts owed to NationsHealth

	 
	 	 	 	d.) Less: Any unpaid amounts due to CIGNA.

	C.	 	Monthly Fee Schedule

	 	 	 
	***	 	Monthly Fee
	***

	 	***
	***

	 	***
	***

	 	***
	***

	 	***
	***

	 	***

Both parties agree to negotiate in good faith a revised fee schedule in the event ***.

	D.	 	Compensation for ***

CIGNA shall compensate NationsHealth for the performance of any *** or *** mutually-agreed upon
rate. Prior to commencing any such *** or ***, NationsHealth must deliver to CIGNA a ***, which
will contain (i) a reasonably detailed description of the ***, (ii) the *** for ***, identified by
***, (iii) the *** corresponding to each ***, (iv) *** of any ***, and (v) a schedule of ***. ***
must be mutually agreed upon and signed by the Parties.

 
 
CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

51

 

The Parties have agreed that ***related to *** generally described in *** is the responsibility of
***, except *** has agreed to *** to support implementation of the *** and changes required by CMS
for the 2007 contract year which will be documented in statements of work as outlined above.

	E.	 	*** Obligation of NationsHealth

If, at any time during the term of this Agreement or any renewal term, NationsHealth or USPG *** is
applicable to CIGNA under this Agreement, then in such event the *** CIGNA to NationsHealth or USPG
shall be ***, subject to the following terms: *** shall not be adjusted for any period of time
during which USPG is ***, except that to the extent NationsHealth and/or USPG is ***, to more than
*** at any given time, then regardless of whether the *** is being met, the *** for any period of
time during which the number of *** from USPG is one of the highest ***, when comparing the number
*** from NationsHealth and/or USPG for each of such ***. For purposes of determining whether
NationsHealth or USPG *** NationsHealth and USPG shall NOT be deemed to be ***: (i) if
NationsHealth and/or USPG is providing both the *** plus any additional *** beyond those being
provided *** (e.g., there is no *** if NationsHealth and/or USPG is *** as well as *** (including
without limitation ***) *** and/or its enrollees beyond those being *** and its Enrollees); (ii) if
NationsHealth and/or USPG is *** to both Part D enrollees and other non-Part D enrollees of such
PDP sponsor beyond the type of CIGNA enrollees receiving services from USPG (e.g., there is no ***
if NationsHealth and/or USPG is providing Services or substantially similar services to both Part D
enrollees and commercial enrollees of such PDP sponsor and USPG is not providing same to both Part
D Enrollees and commercial enrollees of CIGNA); or (iii) if NationsHealth and/or USPG is ***,
rather than a stand-alone Part D prescription drug plan.

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

52

 

Exhibit 10.2

EXHIBIT 1.08

FORM OF JOINT PURCHASE ORDER

	 	 	 	 	 
	Purchase Order Number:
	 	 	 	 
	 
	 	 
	 	 

	 	 	 	 	 
	Date:

	 	 
	 	 
	 

	 	 	 	 

	 	 	 	 	 
	Vendor:

	 	 
	 	 
	 

	 	 	 	 

	 	 	 
	Description of Goods or Service:	 	 

 

 

 

 

 

 

 

 

	 	 	 
	Service Commencement/Delivery Date:	 	 

 

	 	 	 
	Projected Total Cost:	 	 

 

			
	 	 	 
	Payment Responsibility: (Check one) NationsHealth _________
	 	CIGNA ____________

			
	Authorized by:	 	  

	 	 	 	 	 	 	 	 	 
	NATIONSHEALTH, INC.	 	 	 	CONNECTICUT GENERAL LIFE INSURANCE

COMPANY
	 
	 	 	 	 	 	 	 	 
	By:

	 	 	 	 
	 	By:	 	 
	 

	 	 
	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	Date:

	 	 	 	 	 	Date:	 	 
	 

	 	 
	 	 	 	 	 	 
	Authorized Signatories:	 	 	 	Authorized Signatories:
	Glenn Parker	 	 	 	Michael Ferris
	Lew Stone	 	 	 	John Rottkamp
	Tim Fairbanks	 	 	 	Terri Swanson
	Robert Tremain	 	 	 	 

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

53

 

EXHIBIT 1.09

NATIONSHEALTH DEVELOPMENTAL COSTS

NationsHealth Developmental Costs are currently estimated to be ***, which amount represents the
estimated costs for NationsHealth or USPG to develop, implement and deploy the systems,
capabilities and functionalities required to fulfill their obligations and to otherwise satisfy the
requirements under the Agreement including, but not limited to, the following:

	 	•	 	The systems and infrastructure described in Exhibit 1.02, except for item (E).

	 	•	 	The capabilities and functionalities to perform the Services described in Exhibits 1.03
through 1.06 including necessary information and reporting systems.

	 	•	 	Necessary enhancements to NationsHealth and/or USPG systems and capabilities in order to
comply with CIGNA policies, procedures, programs and other requirements that are reasonably
necessary to support the PDP that have not been developed and/or communicated to
NationsHealth or USPG as of the Effective Date of this Agreement.

	 	•	 	Obtaining state insurance licenses pursuant to Section 4.01.

The above cost amount is an estimate. NationsHealth will spend the amounts required for the
purposes described in the first paragraph above, provided, however, that NationsHealth’s
Developmental Costs shall not exceed *** without the prior written consent of CIGNA.

CIGNA shall compensate NationsHealth for the performance of any optional services or developmental
work on a project basis at a mutually-agreed upon rate. Prior to commencing any such optional
service or developmental work, NationsHealth must deliver to CIGNA a proposed written statement of
work, which will contain (i) a reasonably detailed description of the scope of the work to be
performed, (ii) the number of hours required for personnel to perform the work, identified by job
title, (iii) the hourly rate corresponding to each job title, (iv) itemized estimates of any
non-labor expenses, and (v) a schedule of deliverables. Each final statement of work must be
mutually agreed upon and signed by the Parties.

The Parties have agreed that development work related to the ongoing maintenance, enhancement and
regulatory compliance of the systems generally described in Exhibits 1.02-1.07 is the
responsibility of *** to support implementation of the Service Level Requirements and changes
required by CMS for the 2007 contract year which will be documented in statements of work as
outlined above.

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

54

 

EXHIBIT 2.02

CIGNA DEVELOPMENTAL COSTS

	 	 	CIGNA Developmental Costs include:

	 
	•	 	CIGNA internal system modifications required to support the PDP currently estimated at
***.

	 
	•	 	Build up (in late 2005) of operational personnel required to support the PDP currently
estimated at ***.

	 
	•	 	Buildup (in late 2005) of operational facilities required to support the PDP currently
estimated at ***.

These costs are estimates. CIGNA will spend the amounts required to develop PDP capabilities,
provided, however, that CIGNA’s Developmental Costs shall not exceed *** without the
prior written consent of NationsHealth.

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

55

 

EXHIBIT 3.01

INTERIM COMPENSATION

General Principles

The Parties, meaning CIGNA on one hand and USPG and/or NationsHealth on the other hand, intend
to account for the activities described in this Agreement as if such activities constituted a
separate line of business for purposes of sharing the financial effects of certain PDP-associated
expense variances.

No Intent to Create Reinsurance

In agreeing to this arrangement, both parties have independently formed a belief that, in the
event of a loss under any of CIGNA’s Part D contracts covered by this Agreement, this provision
does not give rise to a contract for reinsurance against an underwriting loss by CIGNA. CIGNA
shall bid its Part D Contracts intending to realize net profits and shall, to the extent necessary
and permitted by CMS, charge an additional premium to eligible Enrollees in order to perform the
Part D contracts profitably. The parties acknowledge that the unprecedented nature of the Medicare
Part D product makes it impossible to predict the profitability of the Part D contracts with any
certainty. If CMS, or any other Governmental Authority, were to determine that this profit and
loss sharing arrangement constituted a form of reinsurance, the parties agree to negotiate, in good
faith, an alternative compensation method that approximates the anticipated economic benefits or
obligations of the Parties that will arise under this arrangement.

Interim Compensation

This Exhibit 3.01 provides that certain “Scheduled Marketing and Enrollment Expenses” (set
forth in Attachment A) incurred by CIGNA and/or NationsHealth during the period February 20, 2006
through May 15, 2006 (or such later date to which CMS may extend the initial annual enrollment
period for the 2006 plan year) are amortized over the period from the date incurred through
December 2007, for purposes of determining the expenses to be deducted from Aggregate Actual
Premium in determining the monthly Non-Claim Element Variance.

	A.	 	Definitions

Each of the following shall be as finally determined by CIGNA for applicable periods:

“Actual Aggregate Claims Cost” means actual PDP claims costs incurred by CIGNA or an
Affiliate, net of adjustments required by CMS, including all pharmaceutical company-related
revenues, such as rebates and any other revenues that may be received by CIGNA or an Affiliate as
an offset to claims costs, and all appropriate reserves required by CMS.

“Advanced Expense Payments” means any advanced payments made to NationsHealth from CIGNA.

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

56

 

“Aggregate Actual Premium” means the total premiums received from Enrollees and from CMS.

“Aggregate ***” means the Aggregate ***.

“Aggregate CIGNA ***” means the product of actual Enrollee months multiplied by the CIGNA ***.

“Aggregate CIGNA Target Margin” means the CIGNA Target Margin multiplied by the actual number
of Enrollee months.

“Aggregate Expected Claims Cost” means the product of actual Enrollee months multiplied by the
Expected Claims Cost per Enrollee.

“Aggregate NationsHealth ***” means the product of actual Enrollee months multiplied by the
NationsHealth ***.

“Aggregate NationsHealth ***” means the NationsHealth Target Fee multiplied by the actual
number of Enrollee months.

“CIGNA ***” means a *** amount, calculated as the sum of *** by CIGNA in 2005 *** (the product
of ***), plus, if additional CIGNA *** in any month in 2006, an additional *** amount calculated as
the additional CIGNA *** represents the rate at which ***; provided however, the
Parties understand and agree that the time frame within which CIGNA will recoup the CIGNA *** based
on the CIGNA Development Cost Recovery Rate will be shorter or longer than *** depending upon the
actual number of Enrollees in the PDP in each month and the time period over which CIGNA
Development Costs are incurred). ***.

“CIGNA Developmental Costs” means costs paid by CIGNA for the activities enumerated in
Exhibit 2.02, subject to the limit set forth in Exhibit 2.02.

“CIGNA Funding Charge” means a financing charge of *** or such later date to which *** and ***
in the periodic calculation of the monthly amount due NationsHealth (pursuant to Section D.2.g,
below) through December 2007. No CIGNA Funding Charge will be applied after December 2007.

“CIGNA Service Expenses” means expenses incurred by CIGNA that are specifically, directly and
reasonably related to the operation of the PDP, excluding the expenses incurred by CIGNA or
NationsHealth that are identified in Attachment A (“Scheduled Marketing and Enrollment Expenses”)
to this Exhibit 3.01, Interim Compensation.

“CIGNA Target Margin” means a sum not to exceed *** expressed on a PEPM basis.

“CMS Contract Year Advance Expense Amount Percentage” means the sum of: (i) NationsHealth
Service Expenses that are expected to be incurred during the 12 months of the

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

57

 

upcoming CMS contract year, (ii) the Aggregate NationsHealth Developmental Cost Recovery amount
expected to be realized during the upcoming CMS contract year, and (iii) the NationsHealth Target
Fee that is expected to be realized in the upcoming CMS contract year divided by the amount of
premium expected to be collected during the CMS contract year including bad debt. During the first
CMS contract year the NationsHealth Service Expenses used in this calculation shall exclude the
expected amount of expenses that will be advanced for start-up costs as described in Section C(1),
below.

“CMS Contract Year Month” means a month within a CMS contract year.

“Developmental Costs” means the (i) NationsHealth Developmental Costs plus (ii) CIGNA
Developmental Costs.

“Expected Claim Cost per Enrollee” means the expected claims cost per Enrollee used by CIGNA
in its bid submission to CMS for the PDP pricing based on good faith, best estimate, projections.

“Expense and Profit Premium” means the weighted average of the product of the effective
membership of the month of each of the three plan designs and the portion of the bid intended to
cover the total expense and ***.

“NationsHealth Developmental Cost Recovery Rate” means the sum of NationsHealth Developmental
Costs actually incurred by NationsHealth in 2005 divided ***, plus, if additional NationsHealth
Developmental Costs are incurred in any month in 2006, an additional PEPM amount calculated as the
additional NationsHealth Developmental Costs *** (i.e., the NationsHealth Developmental Cost
Recovery Rate represents the rate at which NationsHealth Developmental Costs would be fully
recovered ***; provided however, the Parties understand and agree that the time
frame within which NationsHealth will recoup the NationsHealth Developmental Costs will be shorter
or longer *** depending upon the actual number of Enrollees in the PDP in each month and the time
period over which NationsHealth Developmental Costs are incurred). Once NationsHealth has recouped
the NationsHealth Developmental Costs, the NationsHealth Developmental Cost Recovery Rate will be
zero.

“NationsHealth Developmental Costs” means costs paid by NationsHealth for the activities
enumerated in Exhibit 1.09 subject to the limit set forth in Exhibit 1.09.

"NationsHealth Target Fee” means ***.

“NationsHealth CIGNA-Funded Interim Service Expenses” means a monthly amount used in
connection with the determination of the Non-Claim Element Variance, calculated as follows:

	 	(1)	 	determine the “Scheduled Marketing and Enrollment Expenses” (as described in
Attachment A) actually incurred by CIGNA or NationsHealth as authorized through the
issuance of a Joint Purchase Order during the period February 20, 2006 through

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

58

 

	 	 	 	May 15, 2006 (or such later date to which CMS may extend the initial annual enrollment
period for the 2006 plan year); and,

	 
	 	(2)	 	amortize such actual Scheduled Marketing and Enrollment Expenses on a level
monthly basis according to the following schedule: such Scheduled Marketing and
Enrollment Expenses incurred from February 20, 2006 through March 2006 shall be
amortized over the twenty-two month period extending from March 2006 through December
2007; such Scheduled Marketing and Enrollment Expenses incurred in April 2006 shall be
amortized over the twenty-one month period extending from April 2006 through December
2007; and such Scheduled Marketing and Enrollment Expenses incurred in May, 2006 shall
be amortized over the twenty month period extending from May 2006 through December
2007.

If CMS extends the initial annual enrollment period for the 2006 plan year beyond May 2006, the
additional Scheduled Marketing and Enrollment Expenses for each month of such extension shall be
similarly amortized on a monthly basis from the month incurred through December 2007. In no event
shall NationsHealth CIGNA-Funded Interim Service Expenses include expenses in connection with any
plan year other than 2006, or include any expenses reported by NationsHealth under any category of
expenses or costs defined herein, other than NationsHealth Marketing and Beneficiary Communication
Expense.

“NationsHealth ***” means actual expenses incurred by NationsHealth for services that consist
of the activities enumerated in Section 1.02 (Part D Capability), excluding (i) those activities
described in Section E of Exhibit 1.02, (ii) those activities performed in connection with
the initial establishment of the capabilities described in Exhibit 1.02, and (iii) and any
major capital investment and any major upgrade unless the treatment for such capital investment and
major upgrade has been reasonably determined by the parties to be a service expense, Section 1.04
(Enrollment Billing and Premium Collection), Section 1.05 (Enrollment and Eligibility), and Section
1.06 (Enrollee Inquiries and Grievance Processing), as well as those beneficiary communication
services enumerated in Section 1.03 that relate to post-enrollment activities only and are not
identified in Attachment A (“Scheduled Marketing and Enrollment Expenses”) to this Exhibit
3.01, Interim Compensation.

“NationsHealth Marketing and Beneficiary Communication Expenses” means actual expenses
incurred by NationsHealth for services that consist of the activities enumerated in Sections 1.03
(Marketing and Beneficiary Communication) provided, however, that such expenses shall
relate to pre-enrollment activities only and shall be identified in Attachment A (“Scheduled
Marketing and Enrollment Expense”) to this Exhibit 3.01, Interim Compensation and shall
have been authorized by the issuance of a Joint Purchase Order.

“NationsHealth Service Expenses” means the total of NationsHealth Enrollment Billing, Premium
Collection, Eligibility, and Inquiry/Grievance Handling Expenses and NationsHealth Marketing and
Beneficiary Communication Expenses

“Non-Claims Element Variance” means the calculation described in Section D (3) of Exhibit
3.01.

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

59

 

“PEPM” means per Enrollee per month.

“Preliminary Actual CIGNA Margin” means the Aggregate CIGNA Target Margin *** the Non-Claims
Element Variance *** the Aggregate Claims Cost Variance for the first CMS contract year
calculation.

“Preliminary Actual NationsHealth Fee” means the Aggregate NationsHealth Target Fee ***.

“Required Target Capital Level” means *** based *** by the ***, or any *** or, in the absence
of such ***,***.

“Start-Up Month” means each of the months from September 2005 through February 19, 2006.

“Supplemental NationsHealth Fee” means a fee to be paid if Preliminary Actual CIGNA Margin ***
and *** is less than ***. In such case, the Supplemental NationsHealth Fee shall be *** or
(ii) ***. In all other instances the Supplemental NationsHealth Fee ***.

	B.	 	Establishment of Target Margin and Target Fee Levels; Year-End Reconciliation.

1.) Annual Identification of CIGNA Target Margin and NationsHealth Target Fee Levels

By May 15, 2005 for the 2006 CMS contract year and not less *** bid submission date (which the
Parties anticipate will be the first Monday in June) for PDP pricing for every subsequent CMS
contract year CIGNA shall specify its required CIGNA Target Margin. PDP pricing shall be
determined by CIGNA.

2.) Year-End Reconciliation 

No later than 180 days following the end of each CMS contract year, CIGNA shall perform a
reconciliation of monthly settlements under this Agreement. As part of such reconciliation CIGNA
will determine and pay to NationsHealth the Supplemental NationsHealth Fee, if any, due to
NationsHealth for the expiring CMS contract year including the reconciliation of all Advance
Expense Payments. See Attachment B.

3.) Termination

A final settlement will be made within 180 days upon termination or expiration of the
Agreement to capture any late reporting of the components used in the Monthly Settlement Process.
No additional adjustment will be made for the unamortized Developmental Costs.

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

60

 

	C.	 	NationsHealth Expense Advance Process

1.) Start-Up Months. Not later than 7 days prior to each Start-Up Month, CIGNA and
NationsHealth will mutually agree to the expected level of NationsHealth Service Expenses for the
upcoming Start-Up Month. CIGNA will make Advance Expense Payments to NationsHealth in two equal
payments of 25 percent (25%) of this amount by the 7th and 21st of the
corresponding Start-Up Month.

2.) Contract Year. Not later than the first business day of each month, NationsHealth will
provide CIGNA with a current estimate of that month’s membership and expenses split between
NationsHealth Service Expenses (excluding NationsHealth Marketing and Beneficiary Communication
Expenses) and NationsHealth Marketing and Beneficiary Communication Expenses. CIGNA will take the
NationsHealth current month expense estimate and reproject expenses for the remainder of the year.
The projected annual NationsHealth Service Expenses (excluding NationsHealth Marketing and
Beneficiary Communication Expenses) are then divided by the projected annual Expense and Profit
Premium to calculate the Advance Expense Percentage. Not later than 5 days following the mutual
agreement of the Advance Expense Percentage, CIGNA will make Advanced Expense Payments to
NationsHealth of the amount of the product of the Advance Expense Percentage multiplied by the
Expense and Profit Premium, net of CIGNA’s current estimate of Enrollee bad debt.

	D.	 	Monthly Settlement Process

1.) Information Deliveries. Not later than 12 business days after the last day of
the preceding month NationsHealth shall furnish to CIGNA, the NationsHealth Enrollment Billing,
Premium Collection, Eligibility, and Inquiry/Grievance Handling Expenses, the NationsHealth
Marketing and Beneficiary Communication Expenses, and the NationsHealth Developmental Costs for the
preceding month. In no event shall NationsHealth submit the same expense under more than one of
the foregoing categories. Not later than 12 business days after the last day of the preceding
month CIGNA shall furnish to NationsHealth the CIGNA Service Expenses, the CIGNA Developmental
Costs, the Scheduled Marketing and Enrollment Expenses incurred by CIGNA and Expense and Profit
Premium. NationsHealth shall furnish to CIGNA the actual PDP enrollment. After a review period of
not more than 10 business days after the date of CIGNA’s delivery of the information described
above, CIGNA shall calculate and pay the amount due to NationsHealth in accordance with this
Exhibit 3.01.

2.) Calculation of Monthly Amount due to NationsHealth

CIGNA shall calculate the amount due to NationsHealth as the sum of the following for the
prior month:

	 	a.)	 	Actual NationsHealth *** Expenses and actual NationsHealth
Marketing and Beneficiary Communication Expenses;

	 
	 	b.) 	 	plus *** of the ***;

	 
	 	c.) 	 	plus Aggregate ***;

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

61

 

	 	d.) 	 	plus Aggregate ***;

	 
	 	e.) 	 	minus the ***;

	 
	 	f.) 	 	minus ***.

3.) Determination of Non-Claim Element Variance. CIGNA shall determine the Non-Claim
Element Variance for each month as follows:

Non-Claim Element Variance shall be determined by subtracting from Expense and Profit Premium
for the prior month all of the following as calculated for the same month:

	 	a.) 	 	***;

	 
	 	b.) 	 	Aggregate ***;

	 
	 	c.) 	 	Aggregate ***;

	 
	 	d.) 	 	Aggregate ***;

	 
	 	e.) 	 	Aggregate ***;

	 
	 	f.) 	 	 ***;

	 
	 	g.) 	 	***; and

	 
	 	h.) 	 	NationsHealth CIGNA-Funded Interim Service Expenses (for
clarification, the monthly amortized amount of the actual Scheduled Marketing and
Enrollment Expenses incurred by NationsHealth and authorized through the issuance
of a Joint Purchase Order.)

Attachment A: Scheduled Marketing and Enrollment Expenses

Attachment B: Demonstration of Year End Variance Illustration

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

62

 

Exhibit 10.2

EXHIBIT 4.03(d)

EXCEPTION TO ***

The Parties acknowledge and agree that *** except that NationsHealth and USPG *** CIGNA shall take
the necessary ***.

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

63

 

EXHIBIT 4.06

BUSINESS ASSOCIATE AGREEMENT

This Agreement, effective ________________, is
by and between ____________________[Insert name of
specific CIGNA Covered Entity], its subsidiaries and affiliates, (“CIGNA”) and _______________
[Insert name of vendor] (“Vendor”).

WHEREAS, CIGNA and Vendor have entered into certain agreements, including but not limited to those
agreements referred to in Appendix “A”, under which Vendor provides certain services to CIGNA; and

WHEREAS, the parties are entering into this Agreement to comply with the Privacy Standards and the
Security Standards as those terms are defined in this Agreement.

NOW THEREFORE, for good and valuable consideration, the receipt and sufficiency of which the
parties hereby acknowledge, and in affirmation of the existing agreements referred to in Appendix
“A”, intending to be legally bound, the parties hereto agree as follows:

			
	I.	 	DEFINITIONS

Capitalized terms used herein without definition shall have the respective meanings assigned to
such terms herein, including Part III of this Agreement. Such defined terms shall supercede
similar defined terms as set forth in the applicable Vendor Agreements.

			
	II.	 	OBLIGATIONS OF VENDOR

Section 1. Use and Disclosure of Protected Health Information.

Vendor may use and disclose Protected Health Information only to carry out the obligations of
Vendor set forth in this Agreement, the applicable Vendor Agreement or as required by law, subject
to the provisions set forth in this Agreement. Vendor shall neither use nor disclose Protected
Health Information for the purpose of creating de-identified information that will be used for any
purpose other than to carry out the obligations of Vendor set forth in this Agreement or the
applicable Vendor Agreement, or as required by law.

Section 2. Safeguards Against Misuse of Information.

Vendor agrees that it will implement appropriate safeguards to prevent the use or disclosure of
Protected Health Information in any manner other than pursuant to the terms and conditions of this
Agreement. Vendor shall implement administrative, physical, and technical safeguards that
reasonably and appropriately protect the confidentiality, integrity, and availability of the
Electronic Protected Health Information that it creates, receives, maintains, or transmits on
behalf of CIGNA as required by the Security Standards.

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

64

 

Section 3. Reporting of Disclosures of Protected Health Information; Reporting of Security
Incidents.

Upon becoming aware of a use or disclosure of Protected Health Information in violation of this
Agreement or upon becoming aware of any Security Incident, Vendor shall promptly report such use or
disclosure or Security Incident to CIGNA in the following time and manner: (i) any actual,
successful Security Incident will be reported to CIGNA in writing within 3 business days of the
date on which Vendor first becomes aware of such actual, successful Security Incident and (ii) any
attempted, unsuccessful Security Incident of which Vendor becomes aware will reported to CIGNA in
writing on a reasonable basis. If the Security Standards are amended to remove the requirement to
report unsuccessful attempts of unauthorized access, this requirement shall no longer apply as of
the effective date of that amendment.

Section 4. Agreements with Third Parties.

Vendor shall ensure that any agent or subcontractor of Vendor to whom Vendor provides Protected
Health Information that is received from CIGNA, or created or received by Vendor on behalf of
CIGNA, agrees to be bound by the same restrictions and conditions that apply to Vendor pursuant to
this Agreement with respect to such Protected Health Information. Vendor warrants and represents
that in the event of a disclosure of Protected Health Information to any third party, Vendor will
make reasonable efforts to limit the information disclosed to the minimum that is necessary to
accomplish the intended purpose of the disclosure. Vendor shall ensure that any agent or
subcontractor of Vendor to whom Vendor provides Electronic Protected Health Information agrees to
implement reasonable and appropriate safeguards to protect such information.

Section 5. Access to Information.

In the event Vendor maintains Protected Health Information in a Designated Record Set, Vendor
shall, within five (5) business days of receipt of a request from CIGNA, provide to CIGNA Protected
Health Information in Vendor’s possession that is required for CIGNA to respond to an individual’s
request for access to Protected Health Information made pursuant to 45 C.F.R. § 164.524 or other
applicable law. In the event any individual requests access to Protected Health Information
directly from Vendor, whether or not Vendor is in possession of Protected Health Information,
Vendor may not approve or deny access to the Protected Health Information requested. Rather,
Vendor shall, within two (2) business days, forward such request to CIGNA.

Section 6. Availability of Protected Health Information for Amendment.

In the event Vendor maintains Protected Health Information in a Designated Record Set, Vendor
shall, within five (5) business days of receipt of a request from CIGNA, provide to CIGNA Protected
Health Information in Vendor’s possession that is required for CIGNA to respond to an individual’s
request to amend Protected Health Information made pursuant to 45 C.F.R. § 164.526 or other
applicable law. If the request is approved, Vendor shall incorporate any such amendments to the
Protected Health Information as required by 45 C.F.R. §164.526 or other

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

65

 

applicable law. In the event that the request for the amendment of Protected Health Information is
made directly to the Vendor, whether or not Vendor is in possession of Protected Health
Information, Vendor may not approve or deny the requested amendment. Rather, Vendor shall, within
two (2) business days forward such request to CIGNA.

Section 7. Accounting of Disclosures.

Vendor shall, within ten (10) business days of receipt of a request from CIGNA, provide to CIGNA
such information as is in Vendor’s possession and is required for CIGNA to respond to a request for
an accounting made in accordance with 45 C.F.R. § 164.528 or other applicable law. In the event
the request for an accounting is delivered directly to Vendor, Vendor shall, within ten (10)
business days, forward such request to CIGNA and any such information as is in Vendor’s possession
and is required for CIGNA to respond to a request for an accounting made in accordance with 45
C.F.R. § 164.528 or other applicable law. It shall be CIGNA’s responsibility to prepare and
deliver any such accounting requested.

Section 8. Availability of Books and Records.

Vendor hereby agrees to make its applicable internal practices, books and records available to the
Secretary for purposes of determining CIGNA’s compliance with the Privacy Standards and the
Security Standards. The practices, books and records subject to this Section shall include those
practices, books and records that relate to the use and disclosure of Protected Health Information
that is created by Vendor on behalf of CIGNA, received by Vendor from CIGNA, or received by Vendor
from a third party on behalf of CIGNA.

Section 9. Return of Records.

Upon the termination of each Vendor Agreement, Vendor shall, if feasible, return or destroy all
Protected Health Information received from, created or received on behalf of CIGNA that Vendor
maintains in any form under such Vendor Agreement, and shall not retain any copies of such
Protected Health Information, or if such return or destruction is not feasible, extend the
protections in this Agreement to such Protected Health Information and limit further uses and
disclosures to those purposes that make the return or destruction of such Protected Health
Information infeasible.

Section 10. Authorization to Terminate.

Vendor hereby authorizes CIGNA to terminate the applicable Vendor Agreement and this Agreement if
it determines that Vendor has violated a material term of this Agreement in accordance with the
terms of the Vendor Agreement.

Section 11. Liability

Any and all matters concerning indemnification and/or limitations as set forth on liability shall
be as set forth in the Vendor Agreement.

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

66

 

			
	III.	 	DEFINITIONS FOR USE IN THIS AGREEMENT

“Designated Record Set” shall mean a group of records maintained by or for CIGNA that is (i) the
medical records and billing records about individuals maintained by or for CIGNA, (ii) the
enrollment, payment, claims adjudication, and case or medical management record systems maintained
by or for a health plan; or (iii) used, in whole or in part, by or for CIGNA to make decisions
about individuals. As used herein, the term “Record” means any item, collection, or grouping of
information that includes Protected Health Information and is maintained, collected, used, or
disseminated by or for CIGNA.

“Electronic Media” shall mean (1) electronic storage media including memory devices in computers
(hard drives) and any removable/transportable digital memory medium, such as magnetic tape or disk,
optical disk, or digital memory card; or (2) transmission media used to exchange information
already in electronic storage media. Transmission media include, for example, the internet
(wide-open), extranet (using internet technology to link a business with information accessible
only to collaborating parties), leased lines, dial-up lines, private networks, and the physical
movement of removable/transportable electronic storage media. Certain transmissions, including
paper, via facsimile, and of voice, via telephone, are not considered to be transmissions via
electronic media, because the information being exchanged did not exist in electronic form before
transmission.

“Electronic Protected Health Information” shall mean Protected Health Information that is
transmitted by or maintained in Electronic Media.

“Individually Identifiable Health Information” shall mean information that is a subset of health
information, including demographic information collected from an individual, and

	 	(i)	 	is created or received by a health care provider, health plan, employer, or
health care clearinghouse; and

	 
	 	(ii)	 	relates to the past, present, or future physical or mental health or condition
of an individual; the provision of health care to an individual; or the past, present
or future payment for the provision of health care to an individual; and (a) identifies
the individual, or (b) with respect to which there is a reasonable basis to believe the
information can be used to identify the individual; and

	 
	 	(iii)	 	relates to identifiable non-health information including but not limited to an
individual’s address, phone number and/or Social Security number.

“Privacy Standards” shall mean the Health Insurance Portability and Accountability Act of 1996 and
the regulations promulgated thereunder, including the Standards for Privacy of Individually
Identifiable Health Information, 45 C.F.R. Parts 160 and 164.

“Protected Health Information” shall mean Individually Identifiable Health Information transmitted
or maintained in any form or medium that Vendor creates or receives from or on

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

67

 

behalf of CIGNA in the course of fulfilling its obligations under this Agreement. “Protected Health
Information” shall not include (i) education records covered by the Family Educational Rights and
Privacy Act, as amended, 20 U.S.C. §1232g, (ii) records described in 20 U.S.C. §1232g(a)(4)(B)(iv),
and (iii) employment records held by CIGNA in its role as employer.

“Secretary” shall mean the Secretary of the Department of Health and Human Services.

“Security Incident", as defined in 45 C.F.R. §164.304, shall mean the attempted or successful
unauthorized access, use, disclosure, modification, or destruction of information or interference
with systems operations in an information system.

“Security Standards” shall mean the Security Standards, 45 C.F.R. Parts 160 and 164, Subpart C.

“Vendor Agreements” shall mean the agreement(s) in Appendix “A”, and any other agreement under
which CIGNA may (a) disclose to Vendor Protected Health Information or (b) Vendor may use Protected
Health Information.

IV. EFFECT OF AGREEMENT

To the extent that this Agreement conflicts with the terms of the applicable Vendor Agreement or
any other agreement between CIGNA and Vendor relating to the confidentiality of Protected Health
Information received or created by Vendor on behalf of CIGNA.

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed in duplicate and
signed by their respective officers duly authorized to do so.

	 	 	 	 	 	 	 	 	 
	Date	 	 	 	 	[NAME OF VENDOR]
	 

	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	 	 	 	By:	 	 	 
	 

	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	Duly Authorized	 	 
	 
	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	Date	 	 	 	 	[NAME OF CIGNA COMPANY]
	 

	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	 	 	 	By:	 	 	 
	 

	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	Duly Authorized	 	 

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

68

 

EXHIBIT 4.07

PERMITTED SUBCONTRACTS

***

***

***

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

69

 

EXHIBIT 5.04

SERVICE LEVEL REQUIREMENTS

			
	A.	 	GENERAL

These Service Level Requirements are an exhibit to the Amended and Restated Preferred Vendor
Agreement dated May 26, 2006, (the “Agreement.”) NationsHealth shall perform the Services set
forth in Article I (“Services and Obligations of USPG”) of the Agreement in accordance with the
terms of the Agreement and the Service Levels set forth in Section B (“Service Levels”) hereof.
Capitalized terms used but not defined herein shall have the meanings ascribed to them in the
Agreement

In accordance with the Agreement, services shall be performed, at a minimum, consistent with
timeliness, accuracy and quality standards set forth in CMS instructions and guidelines. The
Service Levels defined in these Service Level Requirements are specific to standards of timeliness,
accuracy and quality in addition to, or in excess of, the standards that are set forth in the CMS
instructions and guidelines. If CMS increases its requirements with respect to a Service Level
set forth herein such that satisfaction of the Service Level will not meet the new CMS
requirements, such Service Level shall automatically be amended to reflect the new requirements. In
addition, should the performance of CMS, Argus Health Systems, Inc., State Pharmaceutical
Assistance Programs, brokers or agents, or other organizations outside of NationsHealth’s control
directly cause NationsHealth to fail to meet a Service Level, NationsHealth will be relieved from
its obligation to meet such Service Level for so long as such performance by the organization
persists and continues to cause such failure. Any organization which is a direct or indirect
subcontractor of NationsHealth shall not constitute an organization which is “outside of
NationsHealth’s control.”

Frequency of Determination: On a monthly basis, CIGNA will determine whether the performance of
Services met the applicable Service Level Requirements.

			
	B.	 	SERVICE LEVELS

	1.	 	*** Service Levels

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

70

 

a. Timeliness Service Levels

(i) *** required to be *** will be processed and ***.

“Date/time of receipt” means the date/time the paper application arrives at the mail
room, the online application is completed and made available for download by CMS or
an application is taken verbally, as the case may be.

(ii) ***: At least *** will be made to *** for each *** information will be *** of receipt
of ***.

b. Quality/Accuracy Service Levels

(i) ***: No more than *** caused by NationsHealth. A *** of no less than *** will be
performed by NationsHealth. During open enrollment, NationsHealth shall have *** from the
***.

(ii) *** of no less than *** will be performed by NationsHealth. During open enrollment,
NationsHealth shall have ***.

	2.	 	Enrollment Maintenance Service Levels (Maintenance includes: ***

a. Timeliness Service Levels

(i) Processing of Enrollee Initiated Changes: *** of changes initiated by a beneficiary that
must be submitted to CMS will be processed and submitted to CMS within *** of date/time of
receipt; ***.

“Date/time of receipt” means the date/time the paper request arrives at the mail
room, a fax request is completed or a request is taken verbally, as the case may be.

(ii) Processing of CMS Reported Changes: *** updates from the CMS *** will be processed
within *** if there are no *** and there are no new ***.

(iii) Processing of CMS Fallout: ***

	 	•	 	*** will be *** if applicable *** of processing of *** within ***

	 
	 	•	 	*** will be *** and *** to the ***.

b. Quality/Accuracy Service Levels

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

71

 

(i) Quality: No more than *** of all enrollee requested change records ***. *** of no less
than *** will be *** by NationsHealth. During open enrollment, NationsHealth shall have ***
from the *** the application. *** will be ***.

(ii) Accuracy: *** have the desired result: ***. *** of no less than *** by NationsHealth.
During open enrollment, NationsHealth shall have *** the application. *** will be ***.

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

72

 

	3.	 	Fulfillment Service Levels

a. Timeliness Service Levels

(i) ***: NationsHealth will *** of standard Pre-Enrollment material within *** of the ***
within ***, provided a valid *** has been supplied.

(ii) ***: NationsHealth will *** within the timeframes mandated by CMS, specifically
including those documented in *** of the ***.

(iii) *** of all written inquiries will be mailed within ***. This service level is capped
if the number of written inquiries ***and the *** does not override a CMS service
requirement.

(iv) ***: *** will be mailed with respect to *** of all written inquiries *** within *** of
receipt. *** This service level is *** of total membership in the plan *** will still be
responded to per CMS guidelines and the *** does not override a CMS service requirement.

(v) ***: NationsHealth will perform ***. *** updated to note that enrollee has an ***.

b. Quality/Accuracy Service Levels

(i) *** of all *** are fulfilled. *** submitted to *** result in a *** to Enrollee).

	4.	 	Claim Readiness Service Levels

a. Timeliness Service Levels

(i) Sending ***: *** will be sent to *** of the ***.

(ii) ***: *** of *** updates from the *** will be processed and sent to *** within
***.

(iii) ***: *** from files sent to *** issues *** during the *** caused by NationsHealth will
be resolved by NationsHealth within ***.

b. Quality/Accuracy Service Levels

(i) ***: *** of all eligibility records from NationsHealth to *** due to *** caused by
NationsHealth. A *** of no less than *** of the *** will be performed by NationsHealth.
During open enrollment, NationsHealth shall have *** from the ***. *** and ***.

(ii) ***: *** of approved Enrollees have the ***: ***. *** of no less than *** will be
performed by NationsHealth. During open enrollment, NationsHealth shall have *** from the
***. *** and ***.

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

73

 

	5.	 	Billing Service Levels

a. Timeliness Service Levels

(i) ***:

	 	•	 	*** of enrollees who ***, excluding *** prior to August 2006, members with ***,
members where a business *** has been agreed to by CIGNA, and those members ***,
*** by NationsHealth on the ***.

	 
	 	•	 	*** excluding *** prior to August 2006, members with ***, members where a
business *** invoice has been agreed to by CIGNA, and those members***,***.

(ii) ***: *** received at least *** prior to the end of the month, belonging to the plan and
identifiable to an enrolled member, will be *** before the *** before the end of the ***
with the remaining *** by the next ***.

	 	•	 	***: *** all *** will be researched and resolved within *** within *** and ***
within ***.

	 
	 	•	 	*** to a member or Part D adjustment will be reported to CIGNA ***.

(iii) ***: ***, excluding records with ***, will be updated before the ***month for which
the *** is applicable (***before the end of the ***).

(iv) ***: NationsHealth will perform the following *** of members for whom *** has provided
a complete *** with *** that meet the criteria for each step.

	 	•	 	*** of members for whom *** has provided a complete *** with an *** over ***,
NationsHealth will make at least ***, ***, *** within one ***.

	 
	 	•	 	Send an *** and include the *** on the next ***.

	 
	 	•	 	For *** of members for whom *** has provided a complete *** with an *** over ***
NationsHealth will make at least ***, ***, *** within one ***.

	 
	 	•	 	Send an ***.

	 
	 	•	 	Submit *** documentation to CMS for all members who *** and are not *** the ***.

(v) Financial Reporting: NationsHealth will provide the following data feeds and financial
reports on a ***.

	 	•	 	***.

	 
	 	•	 	*** to within *** by the next ***.

	 
	 	•	 	*** and *** to the data feeds.

	 
	 	•	 	*** will be reported to CIGNA with a reason (similar to as listed in *** an
estimated ***.

b. Quality/Accuracy Service Levels

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

74

 

(i) ***, due to a NationsHealth error in ***, *** sent to CIGNA (i.e., no more than *** of
the number of *** on the *** sent by NationsHealth fail to be *** due to a NH error in ***).

(ii) NationsHealth will *** with an *** of not more than ***. A *** of no less than ***
will be performed by NationsHealth. CIGNA may ***.

(iii) ***: *** on a regular basis as outlined below and be provided by the ***.
Specifically:

	 	•	 	CMS Plan *** and *** will be *** by NationsHealth to the *** prior to the ***
and all discrepancies will be reported to CMS with *** until resolved.

	 
	 	•	 	*** will be *** with all differences specifically identified and researched.
The *** for the current ***. The remaining *** by the next ***. All *** items,
not due to a ***, will be *** with *** within ***, *** within *** and *** with in
***.

	6.	 	Call Center Service Levels

a. Timeliness Service Levels

(i) Time to Answer: ***.

(ii) Abandonment Rate: ***.

(iii) Blockage Rate: ***.

(iv) *** Block Calls: NationsHealth will not ***.

b. Quality/Accuracy Service Levels

(i) Quality: *** of calls are routed to *** for *** will be mutually agreed to by CIGNA and
NationsHealth. *** will be based on a ***:

	 	•	 	***

	 
	 	•	 	***

	 
	 	•	 	***

	 
	 	•	 	***

	 
	 	•	 	***

NationsHealth must score within the *** of the time.

(ii) Accuracy: Monitor and review no less than ***

	C.	 	PENALTIES

On a monthly basis, CIGNA will determine whether the performance of ***. Each month the *** will
be ***. The monthly *** and the *** within this section. In no event will the *** measurements
will begin effective not later than October 1, 2006 or as shown in the ***. CIGNA will also work
with
NationsHealth to develop monthly *** related to NationsHealth ***. The *** set forth in this
Section C will not be the exclusive remedy to which CIGNA will be entitled to seek in the event of
a ***.

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

75

 

Exhibit 10.2

	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	NationsHealth ***	 	 	 	 	 	 	 
	***
	 	 	 	 	 	***	 	 	***	 
	***
	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	***	 	 	 	 	 	 	 	 
	 
	 	 	***	 	 	***	 	 	 	 
	 
	 	 	***	 	 	***	 	 	 	 
	 
	 	 	***	 	 	***	 	 	 	 
	***
	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	***	 	 	***	 	 	 	 
	 
	 	 	***	 	 	***	 	 	 	 
	 
	 	 	***	 	 	***	 	 	 	 
	 
	 	 	***	 	 	***	 	 	 	 
	 
	 	 	***	 	 	***	 	 	 	 
	***
	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	***	 	 	***	 	 	 	 
	 
	 	 	***	 	 	***	 	 	 	 
	 
	 	 	***	 	 	***	 	 	***
	 
	 	 	***	 	 	***	 	 	***
	 
	 	 	***	 	 	***	 	 	 	 
	 
	 	 	***	 	 	***	 	 	 	 
	***
	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	***	 	 	***	 	 	 	 
	 
	 	 	***	 	 	***	 	 	 	 
	 
	 	 	***	 	 	***	 	 	 	 
	 
	 	 	***	 	 	***	 	 	 	 
	 
	 	 	***	 	 	***	 	 	 	 

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

76

 

	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	NationsHealth ***	 	 	 	 	 	 	 
	***
	 	 	 	 	 	***	 	 	***	 
	***
	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	***	 	 	***	 	 	 	 
	 
	 	 	***	 	 	***	 	 	 	 
	 
	 	 	***	 	 	***	 	 	 	 
	 
	 	 	***	 	 	***	 	 	 	 
	 
	 	 	***	 	 	***	 	 	 	 
	 
	 	 	***	 	 	***	 	 	 	 
	 
	 	 	***	 	 	***	 	 	 	 
	 
	 	 	***	 	 	***	 	 	 	 
	***
	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	***	 	 	***	 	 	***
	 
	 	 	***	 	 	***	 	 	***
	 
	 	 	***	 	 	***	 	 	***
	 
	 	 	***	 	 	***	 	 	***
	 
	 	 	***	 	 	***	 	 	 	 
	 
	 	 	***	 	 	***	 	 	***
	***
	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	***	 	 	 	 

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

77

 

***

	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	For illustrative	 
	 	 	 	 	 	 	purposes only:	 
	Monthly ***	 	***	 	 	***	 
	***
	 	 	***	 	 	***
	***
	 	 	***	 	 	***
	***
	 	 	***	 	 	***
	***
	 	 	***	 	 	***
	***
	 	 	***	 	 	***
	***
	 	 	***	 	 	***
	***
	 	 	***	 	 	***
	***
	 	 	***	 	 	***
	***
	 	 	***	 	 	***

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

78

 

EXHIBIT 6.03

DATA

1.0 Ownership of CIGNA Data. All CIGNA Data is, or shall be, and shall remain the property of
CIGNA and shall be deemed CIGNA Confidential Information. Other than as necessary for USPG’s or
NationsHealth’s performance under this Agreement, without CIGNA’s approval (in its sole
discretion), the CIGNA Data shall not be (a) used by USPG or NationsHealth, (b) disclosed, sold,
assigned, leased or otherwise provided to third parties by USPG or NationsHealth or to other third
parties or (c) commercially exploited by or on behalf of USPG or NationsHealth. USPG and
NationsHealth shall not possess or assert liens or other rights in or to CIGNA Data. To the extent
applicable, USPG and NationsHealth hereby irrevocably and perpetually assign, transfer and convey
to CIGNA without further consideration all of its and their right, title and interest in and to the
CIGNA Data. Upon request by CIGNA, and at CIGNA’s expense, USPG and/or NationsHealth shall execute
and deliver any financing statements or other documents that may be necessary or desirable under
any Law to preserve, or enable CIGNA to enforce, its rights hereunder with respect to the CIGNA
Data

1.1 Correction of Errors. USPG and or NationsHealth shall promptly correct any errors or
inaccuracies in the CIGNA Data and the reports delivered to CIGNA under this Agreement, to the
extent caused by USPG or NationsHealth. If requested, and at CIGNA’s request expense, USPG and or
NationsHealth shall promptly correct any other errors or inaccuracies in the CIGNA Data or such
reports.

1.2 Return of Data. Upon request by CIGNA at any time during the term of this Agreement and
upon expiration or termination of this Agreement (or at the end of the Termination Assistance
Period if directed by CIGNA), USPG and or NationsHealth shall (a) promptly return to CIGNA, in the
format and on the media requested by CIGNA, all or any part of the CIGNA Data and (b) erase or
destroy all or any part of the CIGNA Data in USPG’s or NationsHealth’s possession, in each case to
the extent so requested by CIGNA. Any archival tapes containing CIGNA Data shall be used by USPG
or NationsHealth solely for back-up purposes.

1.3 Reconstruction. USPG and NationsHealth shall be responsible for developing and
maintaining procedures for the reconstruction of lost CIGNA Data to the extent the storage of such
CIGNA Data is under USPG’s or NationsHealth’s control. USPG and/or NationsHealth shall correct, at
CIGNA’s request and sole discretion and at no charge to CIGNA, any destruction, loss or alteration
of any CIGNA Data caused by USPG, NationsHealth, or any of their while in USPG’s possession or
under USPG’s control.

1.4 Data Safeguards. USPG and NationsHealth shall establish and maintain safeguards against
the destruction, loss, or alteration of CIGNA Data in the possession of USPG or NationsHealth.

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

79

 

2.0 Ownership of NationsHealth Data. All NationsHealth Data is, or shall be, and shall remain
the property of NationsHealth and/or USPG. Other than as necessary for CIGNA’s performance under
this Agreement, the NationsHealth Data shall not, without NationsHealth’s or USPG’s approval (in
their sole discretion), be (a) used by CIGNA, (b) disclosed, sold, assigned, leased or otherwise
provided to third parties by CIGNA or to other third parties or (c) commercially exploited by or on
behalf of CIGNA. CIGNA shall not possess or assert liens or other rights in or to NationsHealth
Data. To the extent applicable, CIGNA hereby irrevocably and perpetually assigns, transfer and
conveys to NationsHealth and/or USPG without further consideration all of its right, title and
interest in and to the NationsHealth Data. Upon request by NationsHealth or USPG and at
NationsHealth and/or USPG’s expense, CIGNA shall execute and deliver any financing statements or
other documents that may be necessary or desirable under any Law to preserve, or enable
NationsHealth or USPG to enforce, their rights hereunder with respect to the NationsHealth Data.

2.1 Return of Data. Upon request by NationsHealth or USPG, at any time during the term of
this Agreement and upon expiration or termination of this Agreement (or at the end of the
Termination Assistance Period if directed by NationsHealth or USPG), CIGNA shall (a) promptly
return to NationsHealth or USPG, in the format and on the media requested by NationsHealth or USPG,
all or any part of the NationsHealth Data or (b) erase or destroy all or any party of the
NationsHealth Data in CIGNA’s possession, in each case to the extent to requested by NationsHealth
or USPG. Any archival tapes containing NationsHealth Data shall be used by CIGNA solely for
back-up purposes.

3.0 Duplicative Data Fields. The Parties agree that there may be duplicative data fields in
the CIGNA Data and the NationsHealth Data.

4.0 Intellectual Property

4. 1 During the term of this Agreement, USPG and NationsHealth shall assist CIGNA or its
designee, at CIGNA’s expense, in every reasonable way to secure all of CIGNA’s worldwide rights,
title and interest in CIGNA Intellectual Property in any and all countries, including the
disclosure to CIGNA of all pertinent information and data with respect thereto, the execution of
all applications, registrations, filings, specifications, oaths, assignments, confirmation of
assignments and all other instruments which CIGNA shall deem reasonably necessary or appropriate in
order to apply for and obtain such rights, title and interest and in order to assign and convey to
CIGNA, its successors, assigns and nominees the sole and exclusive rights, title and interests in
and to CIGNA Intellectual Property. USPG and NationsHealth further agree that their obligation to
execute or cause to be executed any such instrument or papers shall continue after the expiration
or termination of this Agreement. If testimony or information relative to any of said matters or
related to any interference or litigation is requested by CIGNA either during the term of this
Agreement or following its expiration or termination, USPG and NationsHealth agree to give all
information and testimony and do all things reasonably requested by CIGNA and at CIGNA’s expense.
If CIGNA is unable because of USPG’ s and/or NationsHealth refusal or dissolution to secure a
signature by or on behalf of USPG to apply for or to pursue any application, registration, filing
or other instrument for any United States or foreign intellectual property rights covering the
CIGNA Intellectual Property, then USPG hereby irrevocably designates and appoints CIGNA and its
duly authorized officers

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

80

 

and agents as USPG’s agent and attorney in fact, to act for and on USPG’ s and NationsHealth’s
behalf and stead to execute and file any such application, registration, filing or other
instrument, and to do all other lawfully permitted acts to further the prosecution and issuance of
such intellectual property rights, with the same legal force and effect as if executed by USPG or
NationsHealth.

4.2 During the term of this Agreement, CIGNA shall assist NationsHealth, USPG or its or
their designee, at NationsHealth or USPG’s expense, in every reasonable way to secure all of
NastionsHealth’s or USPG’s worldwide rights, title and interest in NationsHealth/USPG Intellectual
Property in any and all countries, including the disclosure to NationsHealth or USPG of all
pertinent information and data with respect thereto, the execution of all applications,
registrations, filings, specifications, oaths, assignments, confirmation of assignments and all
other instruments which NationsHealth or USPG shall deem reasonably necessary or appropriate in
order to apply for and obtain such rights, title and interest and in order to assign and convey to
NationsHealth, USPG, its or their successors, assigns and nominees the sole and exclusive rights,
title and interests in and to the NationsHealth/USPG Intellectual Property. CIGNA further agree
that their obligation to execute or cause to be executed any such instrument or papers shall
continue after the expiration or termination of this Agreement. If testimony or information
relative to any of said matters or related to any interference or litigation is requested by
NationsHealth or USPG either during the term of this Agreement or following its expiration or
termination, CIGNA agrees to give all information and testimony and do all things reasonably
requested by NationsHealth or USPG and at NationsHealth’s or USPG’s expense. If NationsHealth or
USPG is unable because of CIGNA’s refusal or dissolution to secure a signature by or on behalf of
NationsHealth or USPG to apply for or to pursue any application, registration, filing or other
instrument for any United States or foreign intellectual property rights covering the
NationsHealth/USPG Intellectual Property, then CIGNA hereby irrevocably designates and appoints
NationsHealth and USPG and their duly authorized officers and agents as CIGNA’s agent and attorney
in fact, to act for and on CIGNA’s behalf and stead to execute and file any such application,
registration, filing or other instrument, and to do all other lawfully permitted acts to further
the prosecution and issuance of such intellectual property rights, with the same legal force and
effect as if executed by CIGNA.

5.0 Continued Provision of Services

5.1 Business Continuation.. USPG and NationsHealth shall (a) within 180 days after the
original Effective Date (May 4, 2005), develop a detailed disaster recovery and business
continuation plan, including resource and infrastructure requirements that shall enable USPG and
NationsHealth to provide the Services in accordance with this Agreement, (b) during the term of
this Agreement, implement and comply with the disaster recovery and business continuation services
described in this Exhibit 7.03 and the plans developed pursuant to sub-section (a) above
and (c) test and successfully verify to CIGNA that the disaster recovery and business continuation
plan is fully operational and capable of restoring operations so that USPG or NationsHealth is
providing the Services as contemplated in this Agreement. Upon the discovery by USPG or
NationsHealth of a disaster or business interruption, USPG or NationsHealth shall promptly provide
CIGNA and the impacted CIGNA entities with a notice of a disaster or business interruption or
otherwise affecting the provision or receipt of the Services.

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

81

 

5.2 Implementation of Plan and Restoration of Services. In the event of a disaster
or business interruption (including a Force Majeure Event, as defined below), USPG and
NationsHealth shall implement or cause to be implemented the disaster recovery and business
continuation plan. In the event USPG and NationsHealth do not implement, or cause to be
implemented, the disaster recovery and business continuation plan and restore the Services in
accordance with such plan as set forth in this Exhibit CIGNA may terminate this Agreement in whole
or in part, for cause upon notice to USPG and NationsHealth without regard to any cure period and
CIGNA may pursue any and all available rights and remedies. In the event of a disaster, USPG shall
not increase its charges under this Agreement or charge any CIGNA entity usage fees in addition to
the fees to be paid under this Agreement.

5.3 Force Majeure. If and to the extent that the performance by CIGNA or USPG or
NationsHealth (an “Affected Party”) of any of its obligations pursuant to this Agreement,
as applicable, is prevented, hindered or delayed directly by an act of God, riot, war, earthquake,
acts of terrorism by public enemy, strikes, lockouts or labor disputes or any other similar cause
beyond the reasonable control of such Affected Party (excluding labor disputes or strikes involving
a Party’s own personnel) (each, a “Force Majeure Event”), and such non-performance,
hindrance or delay could not have been prevented by reasonable precautions, then the Affected Party
shall be excused for such hindrance, delay or non-performance, as applicable, of those obligations
affected by the Force Majeure Event for as long as such Force Majeure Event continues and the
Affected Party continues to use commercially diligent efforts to recommence performance whenever
and to whatever extent reasonably possible without delay, including through the use of alternate
sources, workaround plans or other means; provided, however, that the use of such alternate
sources, workaround plans or other means shall cease, upon the cessation of the Force Majeure
Event. For so long as a Force Majeure Event continues, the non-Affected Party shall, upon the
Affected Party’s reasonable request cooperate with the Affected Party. The Affected Party shall
immediately notify the other Party of the occurrence of the Force Majeure Event and describe in
reasonable detail the nature of the Force Majeure Event. The occurrence of a Force Majeure Event
does not excuse, limit or otherwise affect USPG’s obligation to provide either normal recovery
procedures or any other disaster recovery services, except to the extent that such procedures or
services are directly affected by such Force Majeure Event. For the avoidance of doubt but without
limiting the foregoing, each party shall be deemed in breach of this Agreement for failures to
perform its obligations other than failures due to Force Majeure Events.

5.4 Alternate Source. If and for so long as any Force Majeure Event prevents, or
substantially hinders or delays, the performance of any critical Service for longer than the
recovery period specified in the applicable disaster recovery and business continuation plan, CIGNA
may procure part or all of the Services from an alternate source (after consultation with USPG) in
which case CIGNA shall have no obligation to compensate USPG for the Services for time period that
the Services, or part of them, are procured from an alternate source.

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

82

 

EXHIBIT 11.01

SERVICING PROCEDURES

To allow CIGNA to effect a smooth transition in the provision of Services under the Strategic
Agreement the following servicing procedures shall be implemented.

Source Code Escrow: NationsHealth and CIGNA will arrange for a third party escrow agent at CIGNA’s
expense. NationsHealth shall place in escrow the source code of the NationsHealth- developed
software programs the (“Source Code”) used by NationsHealth in connection with the performance of
the Services under the Agreement (the “Software.”) Upon the occurrence of the Triggering
Event (defined below), the escrow agent will release the Source Code to CIGNA upon CIGNA’s written
request, at no additional cost to CIGNA. NationsHealth shall update the escrowed Source Code daily
unless CIGNA specifies less frequent updates.

Back-Up Site Setup and Operation: NationsHealth agrees to replicate the PDP member servicing
capabilities and member servicing database to a back-up site under CIGNA’s ownership or control.
CIGNA shall procure the back-up site, and pay for all direct and indirect expenses and costs
associated with the procurement, management and maintenance of the back-up site. NationsHealth
and/or USPG will provide know-how, expertise, and personnel resources to assist CIGNA, without cost
to CIGNA, in replicating the functionality of the member servicing capabilities and member
servicing database.

Back-Up Site Testing: CIGNA shall have the right to periodically test the PDP member servicing
functions operating at the back-up site to verify the site’s readiness.

Triggering Event: The Triggering Event shall be deemed to have taken place upon the occurrence of
a “For Cause” termination event as described in Section 5.04(e) of the Strategic Agreement, or in
the event that USPG and NationsHealth no longer offer the Services.

Servicing Transition: Upon the occurrence of the Triggering Event, CIGNA may commence production
use of the backup site and perform the Part D member servicing functions without further notice to,
or consultation with, NationsHealth and without electing to terminate this Strategic Agreement.

Grant of License: NationsHealth hereby grants to CIGNA, at no additional cost to CIGNA, a
non-exclusive, non-transferable, non-sublicensable, royalty-free license to use one complete copy
of the Software, including the Source Code once released from escrow upon the occurrence of the
Triggering Event, used by NationsHealth in connection with the performance of the Services under
the Strategic Agreement to enable CIGNA to perform the Services for its own benefit as described in
this Exhibit 11.01. As between NationsHealth and CIGNA, CIGNA acknowledges that the
Software and Source Code are the sole and exclusive property of NationsHealth and that CIGNA has no
rights in the Software and Source Code except those

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

83

 

expressly granted by the Strategic Agreement. For the avoidance of doubt, the license described
herein shall survive the termination of the Strategic Agreement.

Telephone Number Transitioning: Upon the occurrence of the Triggering Event CIGNA shall have the
right to instruct NationsHealth to port the Part D member servicing 800 numbers to CIGNA. CIGNA
shall then control the routing of these 800 numbers.

Servicing Staff Continuity: CIGNA and NationsHealth agree to allow CIGNA to employ up to 10
NationsHealth Part D member services agents to facilitate the continuous provision of the Services.
These member services agents shall continue to perform Part D member services on the NationsHealth
database under the direction of NationsHealth. Upon the occurrence of a Triggering Event, CIGNA
may employ up to 10 other personnel of NationsHealth to facilitate the continuous provision of the
Services. In such event, NationsHealth agrees to waive any applicable non-competes with respect to
such personnel.

 

CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION. ASTERISKS DENOTE SUCH OMISSION.

84

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00108-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00108-of-00352.parquet"}]]